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2 See the core deliverable of SIMPHS 1: F. Abadie, C. Codagnone et al, (2010), Strategic Intelligence Monitor on Personal Health 
Systems (SIMPHS): Market Structure and Innovation Dynamics, available at: http://ftp.jrc.es/EURdoc/JRC62159.pdf 
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ls1 Introduction
1.1 From eEurope to Digital Agenda for 
Europe: eHealth remains a priority
In the descriptive and non-taxonomic 
definition provided in 2004 by the European 
Commission’s eHealth Action Plan, eHealth 
is defined as referring to “the application of 
information and communications technologies 
across the whole range of functions that affect the 
health sector’ and including ‘products, systems 
and services that go beyond simply Internet-
based applications” [1:4].3 This definition more 
or less coincides with what in the US context and 
in many scientific journal articles is referred to as 
Health Information Technology (HIT).4
eHealth has been high on the European 
Commission’s Information Society policy 
agenda for a decade: starting with the eEurope 
framework,5 continuing into i2010 strategy [7], 
and today is part of Pillar 7 (ICT for Societal 
Challenges) of the new Digital Agenda for 
Europe (DAE) for the period 2010-2015 [8:29-
3 An equally illustrative but more organized definition can 
be found in the report drafted by the eHealth task force in 
support of the Lead Market Initiative [2]. In this source, the 
various items of the Action plan definition are grouped into 
four categories: 1) Clinical information systems (specialized 
tools for health professionals within care institutions, tools 
for primary care and/or for outside the care institutions); 
2) Telemedicine and homecare systems and services; 3) 
Integrated regional/national health information networks 
and distributed electronic health record systems and 
associated services; 4) Secondary usage non-clinical 
systems (systems for health education and health promotion 
of patients/citizens; specialised systems for researchers 
and public health data collection and analysis; support 
systems for clinical processes not used directly by patients 
or healthcare professionals. For a definition of Personal 
Health Systems (PHS), a topic that will be taken up again 
later, see Codagnone [3:8-9].
4 In fact, neither expression transmits its real meaning very 
well. ‘eHealth’ suggests only online applications, whereas 
‘HIT’ seems to exclude them. ‘ICT for Health’ would be a 
better expression, yet we stick to ‘eHealth’ and/or ‘HIT’, 
given their more widespread usage. 
5 This framework, whose opening volley was the 1999 joint 
European Council and Commission initiative [4], saw 
the launch of eEurope 2002 [5] in 2000 and then that of 
eEurope 2005[6] in 2002.
30]. Actually, Commission support to what today 
we call eHealth (and earlier went under different 
names such as health telematics) predates its 
systematisation into general information society 
policy as it started in the early 1990s through co-
funded research in the framework programmes 
and has continued since 2007 both through FP 7 
and through the Competitiveness and Innovation 
Programme (CIP) deployment instruments. 
eHealth in 2007 was included among the Lead 
Market Initiatives and in 2011, it will be one 
of the first DAE Flagship initiatives with the 
European Innovation Partnership on Active 
and Healthy Ageing. It must be also stressed 
that healthcare challenges and the potential of 
innovation supported by ICT to tackle them, are 
expressly grounded in the ‘smart pillar’ of the 
overall EU2020 Strategy [9:10].
Stated briefly, the objective pursued by 
eHealth policy is to ‘improve the quality of care’ 
and at the same time ‘reduce medical costs’ 
[8:29]. This objective summarises eHealth’s 
various promises, heralded for more than a 
decade (and very effectively reviewed in Lapointe 
[10]). These include among others:
•	 Reduce medical errors, drug adverse 
events and associated costs (i.e. 
through computerised reporting systems 
for adverse events, ePrescription of 
diagnostic procedures, electronic health 
records, etc);
•	 Improve adherence to prescriptions 
(through reminders and telemonitoring);
•	 Reduce in-patient costs while improving 
health outcomes (telemonitoring);
•	 Support and improve the work of 
professionals in various ways (picture 
archiving and communication systems, 
tele-radiology, computerised physician 
10
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clinical tests results);
•	 Streamline and make more efficient 
hospital administration (Integrated 
computerised systems for billing, order 
entry, discharging, etc);
•	 Increase access and convenience 
for users (eBooking, access to their 
electronic health records, portability 
of their information across the system, 
etc).
Naturally, the Commission is not the only 
stakeholder focussing on, and prioritising, 
eHealth and a recent study [11] has shown how 
an increasing number of Member States have 
developed their own eHealth strategies and 
supporting instruments. Industry is also very 
present with several initiatives and nine European 
Technology Platforms (ETPs).
These efforts in the domain of eHealth have 
resulted in increasing funding and investments 
(see infra), which require evidence on: 
a) the actual deployment and usage of eHealth 
infrastructure and applications in the daily 
practices of the different healthcare system 
tiers (GPs, hospitals, laboratories, etc); and 
b) the contribution of eHealth to the 
achievement of desirable outcomes (benefits) 
for a wide range of potential beneficiaries 
(clinical and health-related quality of life 
outcomes for end users, improved working 
conditions for professionals, increased 
efficiency of healthcare producing units 
to deal with the imminent scarcity of 
professionals and to maintain financial 
sustainability, positive spillover effects such 
as reduction in productivity loss due to 
illness or premature mortality, or new market 
opportunities for innovative ICT companies). 
The first kind of evidence falls within the 
domain of Monitoring and Operational Evaluation 
(M&OE), whereas the second falls into Impact 
Evaluation in the stricter sense.6 The M&OE 
system sets up goals and targets and identifies 
the indicators (and the corresponding data 
gathering) needed to verify their achievement. 
These data can be used in operational evaluation 
which focuses mostly on outputs. M&OE can 
also set targets related to the outcomes sought 
by a policy intervention, but it is outside of their 
scope to causally attribute such outcomes to the 
intervention.  This would require a systematic and 
scientific attempt to prove that changes in target 
outcomes (effects) are due only to the specific 
intervention being evaluated and not to other 
causes.
Benchmarking of policy domains in an 
international perspective is clearly within the 
scope of M&OE, although in the case of the 
eHealth deployment index and of the hospital 
survey data discussed in this report it could 
potentially contribute, if not to impact evaluation 
strictly defined, at least to an implicit evaluation 
of the impact of eHealth (see § 2.2 and § 5.3).
1.2 eHealth in the Commission’s 
benchmarking frameworks and 
activities
All of the three main phases in the European 
Commission’s Information Society policy – 
eEurope for 2000-2005 [4, 5, 6] , i2010 for 
2005-2010 [7], and now the DAE for 2010-
2015 – came with their respective benchmarking 
framework [15, 16, 17]. The treatment of eHealth 
in these benchmarking frameworks and the 
actual realisation of benchmarking exercises 
has not been as systematic as in other areas of 
the Information Society. In 1999, the following 
ambitious targets were identified for eHealth 
[4:14]:  
6 See the 2010 World Bank Handbook on impact evaluation 
for an illustration of this distinction [12:7-22].  A similar 
distinction between ‘Practical Measurement’ and ‘Scientific 
Evaluation’ was introduced earlier (2009) in the Vienna 
Study [13:23-24]. See more on this topic also in [14].
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By the end of 2000:
•	 Healthcare best practices in networking, 
health monitoring, surveillance of 
communicable diseases and in links 
between hospitals, laboratories, 
pharmacies, doctors, primary care 
centres and homes should be identified;
•	 The priorities to be agreed for a number 
of key pan-European medical libraries-
on-line and healthcare expertise centres 
to be operational by the end of 2004;
•	 The priorities in the field of 
standardisation of healthcare 
informatics to be implemented by the 
end of 2000.
By the end of 2003:
•	 All European citizens should have the 
possibility to have a health smart card to 
enable secure and confidential access 
to networked patient information.
By the end of 2004:
•	 All health professionals and managers 
should be linked to a telematic health 
infrastructure for prevention, diagnosis 
and treatment.
Subsequently, when the benchmarking 
framework for eEurope 2005 was established, 
not many of the above targets remained in the 
following two benchmarking indicators selected 
for the whole eHealth field [15:8]:
•	 Percentage of population (aged 16 
and over) using Internet to seek health 
information whether for themselves or 
others.
•	 Percentage of general practitioners using 
electronic patient records.
In the next benchmarking framework defined 
for i2010, eHealth was treated in a somewhat 
generic fashion. It was mentioned only in the 
following: “In the case of e-health, monitoring 
should be done with indicators developed in 
consultation with health specialists, as agreed 
at the first workshop” [16:16]. In the new 
benchmarking framework for the period 2010-
2015, endorsed in Visby in November 2009, a 
two-fold approach was envisaged: 
a) use of online healthcare services (measured 
through the traditional Eurostat survey); 
b) ad hoc surveys on the use of ICT by the 
healthcare system [17:11]. 
This same document mentioned the (at 
the time future) results of the survey of eHealth 
deployment in European hospitals that is the 
object of this report. For the first area of focus 
on online use of eHealth services, two indicators 
were selected[17:18]:
•	 Individuals using Internet to make an 
appointment with a practitioner;
•	 Individuals consulting a practitioner 
online.
No indicators, however, were proposed for 
the second area of focus on the use of ICT in the 
healthcare system.
Ever since 2001, the traditional supply-
side benchmarking of online public services 
(eGovernment benchmarking) carried out on 
behalf of the Commission by Capgemini has 
included “health related services” among the 
20 basic public services, scoring their level of 
availability and sophistication measured through 
a web-based assessment (i.e. public websites are 
scanned and their services given a score on the 
well-known scale from information to transaction). 
This cannot, however, be considered as anything 
close to a benchmarking of eHealth deployment 
in the healthcare sector, for it basically considers 
only two issues and measures whether they are 
mentioned in a website (the survey only checks 
their presence but does not test the actual 
functioning of the services). The first ad hoc 
survey producing some evidence on deployment 
of eHealth in the healthcare industry came in 
2006 as part of a special module of the eBusiness 
12
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launched and three studies were designed and 
then realised. One of these studies is the survey 
producing the results analysed in this report. The 
first was published in 2008 and provided the first 
comprehensive EU27 benchmark of the use of ICT 
among General Practitioners[18]. Then, in 2009, 
the second study was released, providing a state 
of the art of benchmarking practices in Europe 
and beyond on the basis of which a methodology 
for the benchmarking of eHealth deployment 
in hospitals was produced[19]. Next came the 
third study which produced the survey results 
analysed in depth in this report and more widely 
and descriptively presented in the Deloitte/Ipsos 
report [20].
1.3 Objectives and structure of this 
report
Compared to other areas of the Information 
Society, where benchmarking has been 
conducted more systematically for longer (i.e. 
eGovernment), it is evident that benchmarking of 
eHealth deployment is lagging behind. 
In this context, the results of the eHealth 
Benchmarking, Phase III survey, carried out 
by Deloitte and IPSO on behalf of Unit C4 of 
DG INFSO, with the rich information provided 
on about 1,000 European acute hospitals, is a 
strategically important tool to close this gap. As we 
show in more detail later, this survey sheds light 
on key issues such as hospitals’ deployment of ICT 
infrastructure, applications, and much more.
The reasons why benchmarking of eHealth 
deployment is lagging behind are structurally 
related to the multi-dimensional complexities of 
this field, to the relatively greater difficulty/costs of 
getting the data (i.e. data cannot come from web-
based measurement, as it can for eGovernment 
7  http://www.ebusiness-watch.org/ 
benchmarking), and especially to the challenges 
of making sense of the data. 
This report uses multivariate statistical 
methods to analyse with a selective but deep 
vertical focus the results of the above-mentioned 
survey. The objectives of this exercise are two-fold: 
a) to make sense of the results by constructing a 
composite index; b) to extract key policy messages 
and new directions for future research.
The main objective is the elaboration of 
a composite index of eHealth deployment 
with a view to proposing a roadmap towards 
systematised and replicable benchmarking. 
In addition, we also explore the possible link 
between benchmarking and eHealth impact.
Therefore, our focus is much more selective 
but deeper than the broader descriptive analysis 
produced by Deloitte and Ipsos [20]. In addition, 
we do not simply conduct multivariate statistical 
analysis but we put this into a conceptual and 
theoretical perspective and we follow it with a 
discussion of the results and with a set of policy 
and research recommendations.
This first introductory section is followed 
by four more. Section 2 provides the general 
conceptual and theoretical framework for 
benchmarking within an international policy 
perspective. Section 3 presents the data and the 
methodology used. In Section 4, we present 
and comment on the results of our multivariate 
statistical analysis.  Finally, in Section 5 we discuss 
these results and extract recommendations for 
future research and policy making. 
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2.1 From management tool to policy 
instrument: the challenges
Like its predecessor (The Lisbon Strategy 
2000-2010), the new EU2020 strategy will rely 
on the Open Method of Coordination (OMC).8 
Stated very simply (and possibly simplistically, but 
this is not a report about the OMC), this method is 
based on ‘non-binding’ policy instruments at the 
European level (i.e. communications, action plans, 
etc.) plus collective monitoring. The Commission 
and the Member States (MS) agree goals and 
targets and then, in the best application of the 
principle of subsidiary, the implementation of the 
actions needed to reach these goals/targets are 
left to the MS. However, steering and monitoring 
takes place, and periodic benchmarking is one 
8 See for a general introduction and review of this method 
[21].
of the tools used. Accordingly benchmarking has 
assumed a “quasi-regulatory” role and its merits 
and pitfalls have been widely debated [22, 23, 
24, 25, 26, 27, 28, 29, 30]. So, while the use of 
benchmarking in a public sector context is not 
new [31], its growing importance at the European 
level is explained in view of the OMC context. 
One of the issues is how really applicable and 
useful, in a policy context, is an instrument 
that was originally designed and applied as a 
management technique in the private sector.9
9 Benchmarking as we know it today, at least as regards its 
original and more widespread usage in the private sector, was 
first formalised in the late 1970s by the Xerox Corporation, 
as recounted by one of its executives in an article published 
in 1992 [32]. Xerox used benchmarking to compare key 
dimensions of its business to those of Japanese firms. As a 
private sector technique, benchmarking originated mainly 
as a competitive instrument. The most popular definition 
in the management literature is that benchmarking is “the 
continuous process of measuring our products, services, 
and business practices against the toughest competitors or 
Figure 1: Benchmarking typology
Source: adapted from several sources [35, 36, 37].
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Figure 1 summarises and simplifies the 
various distinctions between different types of 
benchmarking, which have been developed for the 
private sector but are also considered applicable 
to the public sector (for general reviews see for 
instance [36, 38, 39]). The important distinction, 
however, is between benchmarking used for 
competition/control purposes and benchmarking 
used for learning purposes. The distinction between 
functional (or specific) and holistic benchmarking 
refers to the unit of analysis (which organisations 
we measure). Functional benchmarking focuses 
on specific issues (task, function, process, product, 
etc), whereas holistic benchmarking focuses 
on an organisation as a whole, comparability 
allowing. Finally at the bottom of the figure we 
have the object of analysis (what we measure) 
which traditionally includes: a) results (any end 
point, be it an output or an outcome); b) processes 
(broadly defined to also encompass the inputs, 
tasks, etc; and c) standards or targets (setting a 
standard of performance or a strategic goal that 
an effective organisation could be expected to 
achieve). Please note that the benchmarking of 
results and of targets often overlap. Leaving aside 
these distinctions, benchmarking in the private 
sector is characterised by a number of features 
that are worth listing as they indirectly identify the 
differences (and increased difficulties) that emerge 
when benchmarking is conducted in the public 
sector, especially at the international level:
1. Learning versus competition/control. 
This distinction is very clear and the 
management literature cited above 
increasingly stresses that results 
benchmarking not matched by process 
benchmarking is not very useful to really 
understand what organisations should 
do to improve their performance and 
catch up with the ‘best in class’.
those companies recognized as industry leaders” [33:10]. A 
more elaborate definition is given by Cowper and Samuels: 
“Benchmarking as an efficiency tool is based on the 
principle of measuring the performance of one organisation 
against a standard, whether absolute or relative to other 
organisations” [34:11].
2. Comparability fairly easy to achieve. 
It is relative straightforward to define 
comparability (industry, products, size, 
etc) and to freely select the appropriate 
sample of comparable units of analysis. 
It is a very different matter to compare an 
entire policy domain within countries, 
where it is not possible to freely select 
only those countries that are more 
comparable.
3. Data constraints not very hard. Finding 
the right data for measurement indicators 
and gathering them is a challenge for 
any form of benchmarking. In the private 
sector, however, data are more readily 
available on several possible objects 
of analysis (inputs, outputs, outcomes, 
processes, etc.) and they can rely on one 
standard and accepted unit of measure: 
the market price.
4. Ownership and compliance less of 
an issue. It is a voluntary instrument 
at least from the perspective of top 
management. Certainly, resistance 
(from middle managers; or from 
country branches toward headquarters) 
may arise and this suggests the need 
for a consensus building approach. Yet, 
the bottom line is that there are strong 
command and control levers in the 
private sector, not to be found in the 
same way in any sort of international 
benchmarking of policies.
5. Optimal feasibility. Benchmarking 
should maximise the relevance and 
validity of the indicators constructed 
through the gathered data and at the 
same time minimise the money/time costs 
needed to collect this data. This financial 
consideration is important in the private 
sector, although when a benchmarking is 
of strategic importance money and time 
tend not to be as constraining as they 
would be in the public sector.
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In the benchmarking of public sector 
organisations and public policies, things are 
more complex as shown in Figure 2 (which 
cross-references the typology in Figure 1). 
Benchmarking a comparable sample of public 
sector organisations with respect to a given object 
of analysis (i.e. service output) is, from a logical 
perspective, very like it is in the private sector 
but with the following differences and increasing 
challenges ([39:433-435]: 
•	 it is more often an exercise imposed 
top down (i.e. a Ministry could 
impose it on the agencies under its 
jurisdiction) and it has weaker levers 
(the headquarters of a corporation 
can obtain compliance from country 
branches more effectively than a 
Ministry from its agencies). 
•	 there is much less emphasis on learning 
in public sector benchmarking, often 
resulting in ritualisation. Concentration 
on indicators rather than on ‘real’ 
performance will result in dysfunctional 
behaviour, where producing data 
becomes an end in itself;10 and 
•	 the less tangible kind of activities of 
public sector organisations, the lack of 
a market prices for the service provided, 
and the little diffusion of granular 
accounting systems (i.e. providing data 
on expenditure broken down into cost 
centres and attributable to groups of 
activities) render the measurement of 
real input, output and outcomes much 
more difficult and/or controversial.
Benchmarking of policies has no equivalent 
in the private sector and so we can characterise 
it in contrast to benchmarking of public sector 
organisations. The two types of benchmarking (of 
policy domains and of public sector organisations) 
10 This relates to the issue of ownership that is very important 
and more problematic in the public sector [27:213]. 
When benchmarking is top down, ownership may be low 
and result in problems of relevance/validity, compliance, 
and cooperation. Lack of commitment can result in 
ritualisation with a focus on measurable results, where 
‘measurable’ is synonymous with ‘easy to gather the data’, 
but not necessarily leading to relevance and validity.
Figure 2: Public sector and policy benchmarking typology
Source: Elaborated from [39, 40].
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can be very different or can, in fact, overlap. 
More traditionally public sector organisations 
are benchmarked to consider their performance 
in terms of service provisions as part of routine 
internal monitoring and Service Level Agreements 
linked to funding. Policies, on the other hand, 
belong to the domain of politics rather than 
public administration and the data to benchmark 
them may come from multiple sources, including 
public sector organisations, and the policy ‘takers’. 
However, in the political domain a policy, once 
enacted, may be followed by investments to 
improve the efficiency and effectiveness of 
public sector organisations. In the latter case, 
benchmarking of public sector organisations 
and benchmarking of policy coincides. A big 
difference remains: while benchmarking of public 
sector organisations can (if one decides so) include 
only very similar ones, benchmarking of policy 
will need to include potentially different types of 
organisations (all those contributing to the policy 
being measured). So, benchmarking policy may 
require the collaboration of very different public 
sector organisations and of other stakeholders, 
which may be reluctant to cooperate or have 
different data and/or measurement systems. All of 
this is related to the scale of benchmarking: the 
larger the scale, the greater the collaboration and 
comparability challenges. It is more manageable 
to benchmark local labour market policies than 
national market policies. It is easier to benchmark, 
for instance, the number of students who graduated 
from a school system (output) than the level of 
labour force literacy (outcome). Last but not least, 
the more complicated benchmarking gets, the 
more important it is to take into consideration 
the processes that produce results or targets, yet 
complexity makes this extremely challenging 
and leads most benchmarks to stop at results and 
targets. In this respect, it goes without saying that 
complexity scales up geometrically when we 
move from the national level to the international 
level.
Benchmarking policy systems is possibly 
even more challenging, since it focuses on objects 
of analysis resulting from the activity of different 
policy domains. A case in point is innovation 
policy that is, in fact, the result of several policies 
such as educational, scientific, SME, patent, 
funding, and many others [27]. The issue of 
where to draw the line between a single policy 
domain and a policy system may be controversial 
and subjective. Indeed, we would argue that 
policies for the Information Society make up a 
system rather than a single domain. Given the 
complexity of the sector to which it is applied, 
we may even go as far as to affirm that eHealth is 
a policy system where support to the introduction 
of ICT in hospitals is a policy domain separate 
from boosting the use of online tools for patients’ 
self-care.
We now sum up the discussion above 
considering a few important technical and 
organisational parameters that any benchmarking 
exercise should take into account, stressing the 
particular challenges concerning the international 
benchmarking of policies.
Validity and reliability of selected 
indicators. According to modern measurement 
theory, a good indicator needs to have validity 
and reliability. Validity has no single agreed 
definition but generally refers to the extent to 
which a measurement indicator is well founded, 
corresponds accurately to the real world and is 
relevant to the object being measured. In other 
words, the validity of a measurement indicator is 
the degree to which the indicator measures what 
it claims to measure. Unfortunately, it is often the 
case that more valid indicators are more costly 
to measure than less valid proxies (which only 
indirectly reflect the object being measured). For 
instance, if one is interested in benchmarking the 
level of social responsibility of large corporations 
in the environmental field, then focussing on 
the presence of internal guidelines on energy 
saving is a less valid measure than focussing 
on energy consumption (or emissions) data, 
although it is certainly easier and less costly to 
find data on the former than on the latter. It goes 
without saying that when benchmarking a policy 
domain at international level, the data gathering 
17
A
 C
om
po
sit
e 
In
de
x 
fo
r B
en
ch
m
ar
ki
ng
 e
H
ea
lth
 D
ep
lo
ym
en
t i
n 
Eu
ro
pe
an
 A
cu
te
 H
os
pi
ta
ls
challenge may force the exercise to rely more on 
proxies and less on the best valid measurement 
indicators, also because high validity may be 
very context specific and pose a trade-off with 
regard to comparability. Reliability concerns the 
consistency, precision and repeatability of the 
selected measurement indicators (more broadly 
of the overall benchmarking). In concrete terms, 
we can look at reliability in two ways: 
a) the value of the indicator Ii of phenomenon 
X measured at time Ti by a research team Y should 
not be too dissimilar from the value of indicator Ij 
applied to the same phenomenon X and measured 
by research team Z at time Tj; 
b) if we take the field of benchmarking 
democracy than the principle of reliability would 
expect that the three most well-known indicators 
(Freedom House, Polity IV and Polyarchy) are 
interchangeable. 
Reliability does not imply validity. That 
is, a measurement indicator may be consistent 
(reliability), but it may not be measuring what 
one wants to be measuring. As measurement 
errors are generally divided into two kinds - 
random error and systematic error - reliability 
concerns random error, whereas validity includes 
systematic measurement error and some random 
error. In terms of accuracy and precision, 
reliability is analogous to precision, while 
validity is analogous to accuracy. It goes without 
saying than measurement indicators should be 
selected to achieve both validity and reliability. . 
It is often the case for international benchmarking 
of policies, however, that reliability (and 
comparability) are achieved at the expense of 
validity.
Comparability. Here political11 and 
technical challenges coalesce and pose complex 
11 In view of the ranking (and the often associated “naming 
and shaming”) that benchmarking tends to produce, 
participating states genuinely or tactically raise the 
comparability issue (selection of one indicator may not 
reflect a country peculiarity).
problems, as can be appreciated in contrast with 
the conditions of private sector benchmarking. 
In the private sector, it is relative straightforward 
to achieve comparability by freely selecting 
the appropriate sample of comparable units 
of analysis (by industry, products, size, etc) 
and standard objects of measurement (profits, 
revenues, processes, costs, etc). This is very 
different from comparing an entire policy 
domain (where the selection of reliable and valid 
indicators is difficult in itself) within countries and 
one cannot freely select only those countries that 
are more comparable. Sovereign states want to be 
compared in ways that reflect their peculiarities, 
which is also a technically legitimate issue related 
to the choice of criteria and indicators. This choice 
is not easy since the definition of policies in 
terms of input, output, and outcome performance 
is never intuitive and is affected by national 
particularities and international trends, which 
complicate the selection of indicators.  In this 
context, indicators for international benchmarking 
should be easy to interpret, stable and consistent 
to monitor and, at the same time, reflect (validity) 
the complexity of the phenomena they aim to 
measure [41:352-353]. Comparability must then 
be achieved by selecting only those indicators that 
can best reflect the peculiarities of all countries 
and whose value cannot be criticised by Member 
State representatives on grounds that they do not 
reflect country-specific institutional arrangements 
and various other matters. As anticipated, this 
search for comparability as a minimum common 
denominator may result in the selection of less 
valid measures. We must, however, recall the 
simple common sense fact that it does not make 
sense to compare identical things since only what 
is at least reasonably different is worth comparing. 
So, the comparability issue will always remain a 
source of potential ambivalence and debate and 
will often be used as a criticism from those who 
do not like the results of the comparison;
Transparency. The methods for gathering 
the data, calculating the indicators, and creating 
composite indexes should be fully explicit so that 
others can re-use them and verify their validity 
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and reliability. This is of utmost importance as 
regards reliability and the objections that could 
be raised concerning comparability. A very 
transparent methodological set up will enable 
other researchers to replicate the approach and, 
thus, test its reliability. Transparent choices will 
also provide the grounds for open and rational 
discussions by others about the comparability of 
the benchmarking approach selected.
Cooperation and feasibility. International 
benchmarking of policies entails a complex 
and time consuming consensual process among 
sovereign states [38:321]. Once a consensus 
is reached, then the issue raises of vertical 
cooperation. Each state has to ensure that the 
lower levels of the public sector, which deal 
with the policy being benchmarked, provide 
the necessary data.  In most cases, data from 
outside the public sector will also been needed. 
has to impose a request of the needed data on 
the lower layers of the public sector dealing with 
the policy benchmarked and in most cases also 
needs to obtain data from outside the public 
sector. Since gathering data and measurement is 
time consuming and requires real commitment 
and awareness, it would be naïve to expect all 
relevant lower public sector layers to already 
have an ongoing system for data gathering and 
monitoring. Some more sophisticated lower levels 
may have in place a system of data gathering and 
measurement, defined for their own purposes - in 
many cases, before the higher level benchmarking 
is launched. The chances are very high that the 
objects, definitions, and data gathered by these 
micro-level evaluation and measurement systems 
do not coincide exactly with those of the higher-
level benchmarking and differ across different 
public sector bodies. Under these circumstances, 
making micro-level data comparable for higher-
level benchmarking is a daunting task. So, the 
costs of such complex international benchmarking 
tend to be high.
There are several possible solutions to the 
challenges explained above, which are, however, 
beyond the scope of this report. We therefore 
limit ourselves to anticipating the ways in which 
the survey of eHealth deployment in European 
hospitals and our analytical approach described 
in Section 3 should address them.
First, the indicators that we use and re-
elaborate in this report come from a very 
extensive and granular set of questions asked 
directly to individuals involved in the day-to-day 
administration and usage of the phenomenon 
we aim to measure. So, the validity of the base 
indicators is extremely high. The way we aggregate 
base indicators into sub-components, dimensions, 
and finally the composite index (see Section 3) is 
based on both theoretical/conceptual reasoning 
and sound multivariate statistical analysis that we 
claim retain the validity of the base indicators.
Second, our approach to the analysis 
described later is methodologically sound and 
should ensure reliability. The detailed illustration 
of our approach, besides fully meeting the 
transparency requirement, will enable other 
researchers to replicate it and eventually test our 
claims as to the validity and reliability of our 
measurement.
Third, with respect to the comparability 
issue, we can repeat that the sample used is 
representative of the overall universe of acute 
hospitals in the European countries considered, 
the same kind of respondents (Chief Information 
Officers and Medical Directors) were interviewed 
in all countries in their own native languages, and 
they were asked the same set of questions. We 
checked the overall consistency of the answers 
across different countries and different types of 
hospitals and found no clear patterns of missing 
data and/or of counter-intuitive results, which 
ruled out the possibility that the questions were 
misinterpreted. In addition, as we show later, we 
cross-plotted the results of our measurement with 
external data, obtaining results that corroborate 
the comparability of our measures (i.e. those 
countries obtaining a higher score in our 
composite index are also those where per capita 
spending on ICT in healthcare is higher).
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Finally, as to the issue of cooperation and 
feasibility, it is clear that the decision to outsource 
an ad hoc survey to a third party was made to 
avoid problems with gathering administrative 
data and aggregating them bottom up. As we 
mentioned later, this decision may be criticised 
in terms of its future sustainability (if the survey 
is not repeated) and of ensuring temporal and 
spatial reliability and comparability (surveys done 
at different times or in different geographical units 
may not be fully comparable). This is indeed a 
topic worth discussing in general (see § 2.3) and 
as part of the future benchmarking agenda (and 
we do so in Section 5), but it was something we 
took as a given and does not affect the quality 
of the measure we developed using the data that 
were available to us.
2.2 Holistic international policy 
benchmarking
Going back to the debate in the literature 
on benchmarking within the context of OMC, 
we should also point out that the tendency of 
international policy benchmarking to focus 
on results/targets rather than on processes 
is criticised. Indeed, the goals of this policy 
coordination mechanism should be both 
monitoring and policy learning/ transfer [22, 
42, 43, 44]. OMC-benchmarking should be, it 
is argued, not only competitive for control and 
monitoring purposes, but also cooperative and 
about learning from others (with focus on what 
produces results/standards). Because in practice 
OMC-Benchmarking has been rarely conducted 
in this way it has been criticised on various counts 
[30, 36, 38, 40, 45]. The challenges discussed 
earlier make international policy benchmarking 
into a lengthy and costly process, which results 
in the tendency to focus on broad quantitative 
measures of inputs or outputs rather than on 
the actual processes involved.  So, international 
policy benchmarking is rarely about learning and 
continuous improvement and is mostly about 
target setting and quantitative measurement, 
which may encourage participants to manipulate 
the evidence to what is seen to be required. 
In other words benchmarking can turn into 
producing self-referentially acceptable images of 
performance. Evidently, focusing on high level 
synthetic numbers is much easier than analysing 
the contingent and multi-dimensional reasons 
for the differences behind them [46:236]. So, it 
betrays the promise of a  “learning process for all” 
[22]. As put it by Room “benchmarking through 
indicators is severely limited in what it can offer. It 
may need to be accompanied by ‘benchlearning’, 
involving the exchange of narratives, case studies 
and ‘stories’, which integrate these indicators into 
coherent accounts of how change practically 
occurs” [30:126]. Following such critiques, one 
could argue that in the ideal world a full-blown 
and optimal policy benchmarking system should 
look like the one portrayed in Figure 3.
The graphic sketch conveys the message that 
a complete international benchmarking of policy 
presupposes a clear links and reciprocal feed 
back loop between benchmarking for monitoring 
(basically focussed only on high-level quantitative 
indicators of results/targets) and benchmarking 
for learning. The latter should focus on further 
exploring what explains the  differences in results 
identified by ´benchmarking for monitoring´ 
and especially the point of excellences (best 
performers) and the gaps (worst performers). This 
learning (from the perspective of policy) can also 
be seen as ‘understanding’, or to put it the other 
way around analysing the factors producing the 
results that can help extract the policy learning. 
In the broadly defined field of ICT adoption and 
usage, for instance, benchmarking for learning 
should focus on , among others, the following 
objects of analysis: a) input (monetary, but 
possibly also in terms of strategic leadership); 
b) re-organisation and change management 
activities (analysed more in depth with qualitative 
methods for a selected number of cases or 
assessed with open or structured questions in 
survey questionnaire leading to quantification 
through dummy or ordinal scale variables); c) 
intra and inter organisational integration and 
joined up delivery. 
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From these considerations and from the 
graph in Figure 3 what is important for us to stress 
is that linking the two forms of benchmarking 
can also provide insights into the issue of impact. 
Alternatively, if a full holistic approach is not 
possible, at least some questions should be added 
in ad hoc survey for monitoring benchmarking 
that would enhance also the agenda of measuring 
impacts. For instance, in the specific context 
of this benchmarking exercise on eHealth 
deployment in hospitals additional questions on 
relevant parameters (i.e. monetary expenditure for 
ICT per hospitals, hospitals output, information 
on re-organisation) could have helped us 
measure issues of impacts that in Section 4 (§ 4.3) 
we have touched only in a very preliminary and 
hypothetical way. In this respect a brief digression 
is in order here to illustrate how important and 
urgent is the issue of impact measurement in the 
eHealth policy domain.
In recent years, throughout the globe 
we have witnessed an unprecedented effort 
to affect population health outcomes by 
leveraging technology in healthcare delivery. 
According to WITSA data between 2003 and 
2011 the USA will have spent approximately 
$ 500 billion, Western Europe12 $ 531 billion, 
Eastern Europe13 $ 25 billion, and Japan $ 128 
billion [47]. Another source14 indicates that 
investments in HIT have grown substantially 
and in most countries account for between 2% 
and 6% of total healthcare spending, that is to 
say in many cases more than what is spent for 
prevention activities. As noted by Christensen 
and Remler [48:4], the extraordinary potential 
of ICT in healthcare has been heralded by many 
12 Includes Norway, Switzerland and Turkey, but does not 
include Malta, Cyprus, Luxembourg, and Iceland.
13 Including also Russia and Ukraine.
14 Market research company IDC data reported in [10].
Figure 3: Holistic approach to policy benchmarking
Source: adapted from [36:25].
21
A
 C
om
po
sit
e 
In
de
x 
fo
r B
en
ch
m
ar
ki
ng
 e
H
ea
lth
 D
ep
lo
ym
en
t i
n 
Eu
ro
pe
an
 A
cu
te
 H
os
pi
ta
ls
commentators, whereas others bemoan that it 
is not meeting the expectations. As of today the 
evidence we dispose of on the impact of eHealth 
on both quality of care and cost containment is 
not conclusive and does not allow us to emit a 
verdict on which of the two sides (optimist and 
pessimist) is correct. The evidence on eHealth 
cost-effectiveness is inconclusive as discussed 
in several reviews and meta-reviews [3, 10, 49, 
50, 51], despite the number of studies evaluating 
eHealth impacts is growing exponentially: 
in 2002 652 such studies only focussing on 
telemedicine were identified for the period 1980-
2000 [50]; in 2006 252 evaluation studies of 
more broadly defined eHealth were found for 
the period 1994-2005 [49]; an additional 1300 
such studies published from 2005 until 2009 
were identified [10]. Alongside studies reporting 
improvement on quality of care, for instance, 
one can find also those reporting zero or even 
negative impacts [10:2]. Trying to make sense of 
this situation the “Productivity Paradox” has been 
applied to healthcare settings [10]. Robert Solow 
famous quip that “You can see the computer age 
everywhere but in the productivity statistics”15 
was later systematised into the so called 
Productivity Paradox [52, 53], the ‘paradox’ being 
the remarkable advances in computer power and 
in IT investments by firms and the relatively slow 
growth of productivity at the level of the whole 
economy (at least in the period 1970-1990). 
The initial main explanations of this `paradox` 
were measurement errors, and lag in the full 
manifestation of the benefits of introducing IT 
in firms, non-distribution of profits. As shown 
[14], however, subsequent research partially 
reverse the paradox as after the 1990 productivity 
resurgence was attributed also to ICT in macro-
economic models, and micro-economics studies 
showed that ICT does increase the productivity 
of firms especially when occurred together with 
re-organisation, change management, and re-
training of employees. Firms started to really 
leverage IT when they were fully capable also 
15 R. Solow, We’d better watch out. New York Times, July 12, 
p. 36.
to capture and mine customers’ data and to use 
ICT to integrate the value chain both upstream 
(supply chain) and downstream (delivery), as 
well as to better connect with inter-organisational 
networks of cooperation. Let us now make a 
parallel between the world of firms and that of 
healthcare in order to advance our hypothesis 
on the Productivity Paradox of HIT. Healthcare, 
mutatis mutandis, must also engage in internal 
(to the various establishments) re-organisation, 
change management, training of personnel before 
ICT will show its full impacts. Yet, full realisation 
of ICT benefits will come only when the latter 
will support integration across healthcare tiers 
and vertical specialities. Healthcare is probably 
the most information intensive of all industries 
and the information mostly concerns individuals, 
their situation, their health status and their 
response to treatments. Even the good application 
of drugs and use of medical technology depends 
on the availability of the relevant information, 
in the right time, and at the right place. Such 
information centred on the person comes and is 
stored in many different places within and outside 
the healthcare system. It can be found across the 
different tiers of the healthcare system (primary, 
secondary and tertiary care) within vertical 
specialisms. It is also found in clinical guidelines 
and pathways and in state of the art clinical and 
biomedical research. Hence, the re-organisation 
and change management needed to fully exploit 
HIT must reach out, through integration across 
tiers and vertical specialties, between practice 
and research, and also engage the users, who 
if they could access online their EHR could use 
it for various purposes and could also add their 
own data (i.e. about lifestyle parameters16). In this 
respect with agree with the OECD that places 
users access to their EHR into the impact stage 
in their model going from eHealth readiness to 
eHealth intensity up to eHealth impact defined 
as information and service quality [55:81]. It is 
our hypothesis that the evidence on eHealth 
cost-effectiveness is still inconclusive for two 
16 On this see the IPTS report on the health value of crowds 
sourcing [54].
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integrated reasons: a) measurement errors and 
lag time; but also b) lack of broadly defined re-
organisation and change management. The latter 
may better explain the contradictory finding of 
cases reporting no or negative impacts and cases 
reporting full-blown positive impacts.
One may be left wondering how does this 
apparent digression bears relevance to the topic 
of this paragraph and to the focus of this report in 
general. First, it is an illustration of the suggested 
benefit of linking ‘benchmarking for monitoring’ 
to ‘benchmarking for learning’ for impact 
assessment (contained in Figure 3). Results of 
benchmarking also the processes could be crossed 
with analysis of cost effectiveness to make better 
sense of them. Second, anticipating the content 
of § 4.3, the results of the eHealth Benchmarking 
Phase III survey contains interesting perceptions 
from hospitals’ Medical Directors on the 
impact of Electronic Patient Records (EPRs) and 
Telemonitoring that could be better understood 
If we had had also information on processes and 
input (see § 4.3.3 and § 5.3).
2.3 State of the art and eHealth 
benchmarking 
In § 1.2 we have already provided a 
brief overview of the development of eHealth 
benchmarking within the Commission 
framework, from which we concluded that the 
only benchmarking of the health sector available 
is the survey on ICT adoption and use by General 
Practitioners[18]. Here we will very briefly 
extend this overview by selectively and briefly 
summarising the impressive and extensive work 
conducted as part of the eHealth Benchmarking 
Phase II [19], as well as looking at three OECD 
reports [55, 56, 57]. 
The eHealth Benchmarking Phase II report 
overviewed eHealth benchmarking activities in 
the 27 Member States of the European Union, 
Iceland, Norway, Canada and the United States 
and indentified 94 sources [19].  The results 
from the analysis of these sources have been 
summarised as follows: a) in 74 cases data 
came from surveys, in 15 cases from scientific 
reports, and only 5 case from administrative 
performance monitoring processes; b) 74 were 
on availability and use of eHealth in various 
settings (not only hospitals), 10 on evaluation 
of eHealth application impacts, 7 on attitudes 
and perceptions, and 3 on eHealth market 
development (Meyer et al 2009: p. 2). The 
OECD analysed the practices in 9 countries 
(Australia, Canada, Czech Republic, France, 
Finland, New Zealand, Norway, Sweden, and 
United States) and then integrated this analysis 
with the results at the EU level [55].17 The 
conclusion is that most OECD countries (except 
Finland18) do not systematically gather data for 
eHealth benchmarking [55:82] and that more 
in general considering both OECD and EU27 
the situation is far from ideal with various 
problems including: a) lack of conceptual inter-
operability (EHR and other items being defined 
differently); b) ad hoc basis of surveys limiting 
comparability of results across time and space; 
c) the use of very many and different indicators 
[57, 58].19 As seen, the eHealth Benchmarking 
Phase II shows that the overwhelming majority 
of identified cases (74 out of 94) focussed on 
availability and use [19:2].
For what concerns our interest here, both 
from the OECD [57] and from Meyer et al [19], 
we can derive that there are two main sources of 
data for benchmarking of eHealth: a) stand alone 
surveys of healthcare personnel or organisations; 
b) administrative data.  The comparison of the 
17 Basically the 2010 OECD [55] report integrates the data 
presented in the earlier 2008 one[57]  with those provided 
by Meyer et al [19]. So, as it comes afterwards and look 
in a combined way at a large number of countries, we 
can say that the 2010 OECD report is more updated in 
providing conclusive findings on the state of the art.
18 In Finland ICT adoption in the various sub-systems of 
healthcare has been monitored regularly since 2005, 
whereas administrative data have also been used (though 
not in the same systematic fashion) also in Norway, Spain, 
and Sweden [55:82]. 
19 Meyer et al report [19:2] have found a total of 4400 
indicators from the 94 sources identified and analysed.
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two sources in terms of relevance, feasibility, 
and comparability leads us to conclude that, at 
least in the short term, surveys are a more viable 
solution, despite their longitudinal and cross-
sectional comparability problem. As we illustrated 
earlier (§ 2.1), producing international policy 
benchmarking from data aggregated from lower 
level administrative units poses serious challenges 
of cooperation, compliance, and measurement 
capabilities, which reduce the feasibility of this 
approach in the short term.20 
On the other hand, the ad hoc surveys 
produced so far do indeed show clear limits of 
comparability. They tend to be commissioned 
and/or implemented by organisations pursuing 
different policy and/or research interests, thus, 
resulting into different focus, operationalisation 
of the objects of measurement, indicators, not 
to mention incomparable units of analysis. In 
addition, rarely such surveys are repeated on 
a regular basis to allow at least longitudinal 
comparison. This notwithstanding, we see 
the survey as a promising approach in the 
short term also as a way to gradually design 
and refine a eHealth benchmarking survey 
model that could be agreed upon and 
adopted by international organisations such 
as the European Commission, the WHO, and 
the OECD. Moreover, the survey approach 
may enable: a) to combine both results and 
process as in the overall and ideal policy-
benchmarking framework (see Section 2.1); 
and b) link benchmarking to impact evaluation. 
With respect to this last point ideally in the 
mid to long-term surveys and administrative 
data could be integrated as sources for holistic 
eHealth benchmarking capturing information 
about deployment, usage, 
20 As we argued earlier, administrative units may gather 
not the most relevant data (ritualisation) and even if we 
find administrative unit X and administrative unit Y with 
state of the art monitoring systems chances are that the 
data gathered and indicators constructed will be different 
(especially if they are from different countries).
Singling out from the work reviewed by 
the OECD [55, 57] and by Meyer et al [19] 
the contributions strictly focussing on eHealth 
deployment within hospitals we can characterise 
them in terms of the typology presented earlier 
(see Figure 1 and Figure 2). Despite nuances and 
differences, they all tend to be functional policy 
benchmarking focussing on results or target 
(with only very limited cases considering also 
processes). They focus on one domain of policy 
(eHealth) and not on an entire policy system and 
they do it in a more functional (specific) way: 
considering only one sub-sector (the hospitals) 
and focussing not holistically on all possible 
dimensions but simply on the availability and 
adoption of ICT (hospitals general descriptive 
data are gathered, but no information on core 
activities are included). The survey completed 
by Deloitte and Ipsos as part of the Commission 
eHealth Benchmarking Phase III study falls also 
into this typology. As it will become clearer from 
the presentation of data and results in the next 
sections, this survey focuses on availability and 
use of ICT infrastructure, on eHealth applications, 
on electronic data exchanges functionalities, and 
on data security and privacy. It predominantly 
focuses on results, in the sense that by gathering 
the above mentioned data the main goal is to 
assess what level of availability and use European 
acute hospitals have reached after the last decade 
of intensive investments in ICT. In other words, 
it is well known that a large number of eHealth 
implementation projects took place in the past 
ten years and this survey tells us what are the 
results in acute hospitals in terms of availability 
and use of infrastructure and functionalities. In 
addition, the respondents to the questionnaire 
were also asked questions about perception of 
the impacts of using ICT in the hospitals and 
about barriers to adoption. This was already a 
very daunting task and produced the best and 
most update information available today in 
Europe and represents a great contribution to 
our understanding of the process of eHealth 
development. Unfortunately, the survey does not 
contain information on organisational changes, 
on the input (monetary and non monetary) behind 
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the registered level of deployment, and on the 
extent to which these results in ICT adoption and 
use can be matched to cross-sectional (across the 
various hospitals) differences in output. As we 
argue later, these additional elements could be 
the object of a future follow up.
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As anticipated, our work focuses on the 
multivariate statistical analysis of the results of 
the eHealth benchmarking III survey and more 
specifically on the construction of a composite 
index of eHealth deployment and also on the 
elaboration of cluster analysis from the answers 
of Medical Directors about eHealth impacts. We 
will not, therefore, enter into a detailed analysis of 
descriptive statistics that can be found elsewhere 
[20]. In this section we first briefly report basic 
information about the survey implementation 
parameters, we then discuss generally the 
debated issue of constructing composite indexes, 
and conclude illustrating the approach we have 
followed. The results of the analysis are presented 
in Section 4. 
3.1 Survey data collection, universe, 
and sample 
The data were collected through CATI 
telephone interviews with representatives of 
acute hospitals in 30 countries in Europe. The 
interviews took place between mid-July and mid-
September 2010. Two different questionnaires 
to two different target groups were administered 
in the survey, one for Chief Information Officers 
(CIOs for all of the hospitals) and one for Medical 
Directors (MDs only in 280 hospitals). The 
interviews lasted an average of 30 minutes. 
The CIOs questionnaire included five main 
blocks related to: 
- Characterization of the hospital; 
- Infrastructure, availability and 
connectivity; 
- Applications; 
- Integration; 
- Security and privacy. 
The MDs questionnaire also included five 
main blocks related to:
- Utilisation of applications; 
- Investment priorities; 
- EPR impact and barriers; 
- Chronic disease management 
programmes impact and barriers;
- Telemonitoring impact and barriers.
The universe of reference was the entire 
population of acute hospitals (in terms of size, 
ownership and region) in each of the EU 27 
member states as wells Croatia, Iceland and 
Norway. The national Ipsos network members 
gathered the latest and most accurate information 
to identify the full universe of acute hospitals in 
the 30 countries, from which the sample was 
extracted. 
The sample was extracted randomly with 
quota stratification by region, size (number 
of beds) and ownership (private/public). The 
stratified quota random sample extracted is 
statistically representative of the universe 
as previously defined and consisted of 906 
hospitals. In all 906 hospitals the CIO was 
interviewed and in 280 also the MD responded, 
for a total of 1,186 interviews. It is important 
to note that all the Medical Directors surveyed 
belonged to the same hospital as the hospital’s 
CIO, which means that MD and CIO answers 
can be matched and compared. More detailed 
information on sampling and other survey 
implementation issues can be found in the 
Deloitte/Ipsos report[20].
3.2 The controversy on composite 
indexes
When benchmarking is applied to complex 
policy issues it inevitably produces a large 
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of summarising them into a more unified and 
compact policy message. Composite Indexes 
(henceforth simply CI even when used in plural) 
represent a way of providing more compact 
information from large quantity of data, but their 
usage in policy benchmarking is surrounded by a 
never-ending dispute. As put it by Sharpe [59:5]:
 “The aggregators believe there are two major 
reasons that there is value in combining 
indicators in some manner to produce 
a bottom line. They believe that such a 
summary statistic can indeed capture reality 
and is meaningful, and that stressing the 
bottom line is extremely useful in garnering 
media interest and hence the attention of 
policy makers. The second school, the non-
aggregators, believe one should stop once an 
appropriate set of indicators has been created 
and not go the further step of producing a 
composite index. Their key objection to 
aggregation is what they see as the arbitrary 
nature of the weighting process by which the 
variables are combined.” 
We have summarised the pros and cons of 
composite indexes in Table 1 overleaf where the 
contents of each cell is very detailed and self-
explanatory and do not require further illustration 
and discussion. Despite the controversy on CI 
and their limits, the complexity of international 
benchmarking makes them a necessity. Moreover, 
CI can at time provide effective messages that 
policy makers can capitalise. The risks and pitfalls 
may be offset by some theoretical and technical 
choices, as for instance following the ten steps 
prescribed and explained for the construction 
of robust composite indexes in the joint OECD-
European Commission-JRC Handbook [60:12-
30]. Out of these ten steps we focus more on four 
of them, since they are very important to illustrate 
and justify the approach we adopted in analysing 
the data of the survey.
1. Apply, if possible, a theoretical/
conceptual framework. It defines the 
phenomenon to be measured and 
its sub-components and the various 
interactions among them. As such 
it should shape the selection of the 
individual indicators (henceforth base 
indicators or base variable) and in some 
case can justify a theory based selection 
of their weights.
2. Select indicators. Assuming we have a 
large set of individual indicators, then 
we may want to select which ones 
should go into the construction of the 
CI (pursuing the objectives of selecting 
those that are most valid, reliable, and 
comparable). In general this selection 
should reflect the theoretical/conceptual 
framework, but it is nonetheless 
advisable to make clear to the audience 
if a peculiar selection may give rise to a 
possible bias.
3. Carry out multivariate statistical 
analysis. A clear-cut and undisputed 
theoretical/conceptual framework 
may not available at all. Or it may be 
available but applicable only to the level 
of the policy domain sub-dimensions but 
not at that of base indicators. With no 
guidance from theory, if base indicators 
are selected and weighted arbitrarily 
and without the analysis of their inter-
relations this can lead to misleading 
policy messages. To offset this risk, one 
can use various multivariate statistical 
analysis techniques to explore the 
underlying structure of the data and 
possibly inductively obtain those 
important inputs not coming from the 
theoretical framework. The two principal 
techniques for this purpose are Principal 
Component Analysis (CPA) and Factor 
Analysis (FA).
4. Carefully and transparently define 
Weighting. This operation should be 
made carefully and transparently since 
different weighting can lead to changes 
in countries rankings (a politically 
very sensitive issue). Many times no 
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weighting is presented as a neutral 
choice but it is not and can produce 
biases. Equal weights it is equivalent, 
in fact, to give each component 
indicator the same weight. If you apply 
equal weights to two highly correlated 
component indicators then this is like 
double counting: ‘if two collinear 
indicators are included in the composite 
index with a weight of w1 and w2, 
than the unique dimension that the two 
indicators measure would have weight 
(w1+w2) in the composite’ [60:21]. Or 
if the individual indicators (variables) 
are grouped into sub-components and 
the CI is constructed from the latter this 
result into an unbalanced structure: 
the sub-components including more 
individual indicators will have more 
weights without this being justified on 
the grounds of any theoretical reasoning 
but only as a result of a not fully thought 
out technical choice. Equal weighting of 
individual indicators selected arbitrarily 
further compound this problem. The 
handbook considers an ideal practice 
to use PCA or FA to estimate weights 
(provided that individual indicators are 
correlated).
3.3 Our approach to the construction 
of a composite index
Firstly, we applied insights derived from the 
scientific literature reviewed [10, 48, 49, 50, 56, 
57] to the various block of information gathered 
through the survey to develop a conceptual-
theoretical framework (see Figure 4). 
As we argued earlier (§ 2.2), to improve 
information and service quality and produce 
effectiveness and efficiency gains in healthcare, 
integration and exchange of information within 
hospitals vertical specialists and between 
hospitals and other healthcare tiers (and also 
across national borders) is fundamental. Also 
important is the extent to which such integration 
and exchange of information directly involve the 
patient making him/her an active co-producer 
of the process of delivery healthcare. For this to 
happen, however, basic and/or more sophisticated 
ICT infrastructure and connectivity are also 
needed. Moreover, the integration must also be 
supported by state of the art eHealth applications, 
which in turn can eventually produce safe health 
outcomes for patients when the needed level of 
data security and privacy is available. Without 
data security and privacy hospital managers and 
also physicians may be reluctant to use eHealth 
application and exchange data for the sake of 
integration. Also patients may be reluctant in 
Table 1: Pros and cons of composite indexes
PROS CONS
Summarise complex or multi-dimensional issues for decision-
makers
If poorly constructed send non-robust policy messages (sensitivity 
analysis needed to test them)
Provide the big picture and are easier to interpret than trying to 
find a trend in many separate indicators, so they facilitate the 
task of ranking countries on complex issues.
“Big picture” may produce simplistic policy conclusions (need to 
be used in combination CI should be used in combination with sub-
indicators to draw sophisticated policy conclusions) 
Help attracting public interest by providing a summary figure 
with which to compare the performance across countries and 
their progress over time.
Involve the selection of sub-indicators, choice of model, weighting 
indicators, treatment of missing values etc (these steps should be 
transparent and based on sound statistical principles)
Help reduce the size of a list of indicators or to include more 
information within the existing size limit
May cause more disagreement among Member States, selection of 
sub-indicators and weights may be politically challenging (again need 
of full transparency)
Increase quantity of data needed (for transparency and robustness 
data are required for all the sub-indicators and for a statistically 
significant analysis).
Source: adapted from [61].
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view of the risks that their data may end up in 
the wrong ends or that breach in security may 
even produce medical errors. Following this 
logic, we conceptually grouped ex ante the raw 
set of questions for which the survey collected 
answers from hospitals CIO into the following 
four dimensions:
- Infrastructure, 
- Applications and integration, 
- Information flow, 
- Security and privacy. 
These four dimensions capture all the base 
indicators produced by the survey questions to 
the CIOs and measure eHealth deployment in 
acute European hospitals in terms of readiness 
and availability.
Second, with respect to these four dimensions 
and their underlying base indicators, we needed 
to decide whether or not to make other ex ante 
choices based on theoretical reasoning, such as 
in particular: a) place or not the four dimensions 
into a sort of linear progression scale (i.e. 
assigning different weights to the dimensions as 
to reflect an increasing level of sophistication 
in deployment); b) select or not only some base 
indicators from the full set of variables generated 
by the answers to the survey for each of the four 
dimensions. 
As to the first question we decided not to 
make an ex ante prioritisation for, whereas one 
could make the argument that infrastructure 
is a pre-condition (so a less advanced level of 
deployment pertaining to the initial creation 
of e-Readiness), we find no strong theoretical 
backing for deciding a hierarchical order of 
importance among infrastructure; applications 
& integration, information flow and legally 
related issues such as security and privacy. 
As for the second question we equally to do 
not find any theoretical model or assumption 
telling us, for instance, that some eHealth 
applications are more relevant than others to 
measure the overall level of deployment, as 
well as that some form of electronic exchange 
is more important than others. We, thus, 
processed through multivariate statistical 
analysis all of the individual based indicators 
to increase the robustness of the approach and 
avoid any arbitrary choice. The four higher level 
dimensions were weighted equally a choice 
that, however, does not create the problems 
of unbalanced structures since the underlying 
sub-components and base indicators are 
weighted through factor analysis.
Third, in view of the previous two points, 
statistical analyses were performed using SPSS 
version 18.0 to confirm the several internal 
complementarities of the variables, by checking 
Figure 4: Holistic approach to eHealth hospital benchmarking
Source: Authors’ elaboration.
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the means and their significant correlation. Factor 
analysis was used to assess items correlations and 
identify common relationships between similar 
items, enabling their categorisation into various 
themes or factors. An analysis of the correlation 
matrix (KMO and Bartlett’s test of sphericity) was 
carried out to check that the correlation matrixes 
were factorable. Data reductions were undertaken 
by principal components analysis using the Varimax 
option to identify possible underlying dimensions. 
The factor analysis was used to carefully and 
transparently define the weights of the lower 
level variables (base indicators) of which the four 
dimensions identified consist. Each base indicator is 
weighted according to its contribution to the overall 
variance in the data. Factor analysis was applied to 
the subsets of base indicators belonging to the same 
dimension. The factors identify sub-dimensions, 
which have been labelled to better understand 
unobserved themes. The relative contribution of 
each of the factors identified to the explanation of 
their variance within each dimension is used as 
weights. To avoid an unbalanced structure of the 
overall indicator due to the different number of 
variables grouped in each dimension equal weight 
(0.25) was assigned to the four dimensions. This 
assumption is also justified theoretically as far as 
each dimension is inter-related to the others. The 
full process described above is rendered graphically 
in Figure 5.
It is worth pointing out that our CI was 
calculated hospital by hospital at aggregate 
European level and that, therefore, the values of 
the CI per country are the average of the hospitals 
within each country. Although each national 
sample drawn is representative of the acute 
hospitals in each country, country comparison 
should be undertaken with caution, the smaller 
the sample, the larger are the margins of errors.21 
To avoid any misinterpretation of the country 
results we have developed Annex 1 “Measurement 
of dispersion of eHealth Deployment Index by 
country”. 
21 See paragraph 2.2.3 in Deloitte/Ipsos report [20] for a full 
disclaimer on this issue.
Going back to Figure 4, we now briefly 
illustrate the following block of the graphs 
included under the heading of exploratory 
analysis. The answers from the survey module 
directed to the Medical Directors (MD) enable us 
to do two things. 
First, some of the answers from MD concerns 
usage of eHealth infrastructure and applications 
and, thus, can be used to map the CI of eHealth 
deployment against intensity of use and explore 
the reasonable hypothesis that the higher an 
hospital is ranked in the CI of deployment the 
more one should expect intensity of use to be. It 
is exploratory inasmuch as we have MD answers 
only from 280 of the total of 906 hospitals 
surveyed and cannot be conclusive. On the other 
hand, since MD and CIO answers can be matched 
to the hospitals where both kind of respondents 
work, we can at least use those of MD to partially 
check the validity of the eHealth deployment CI.
Second, MD provided answers on their 
perceptions of the impact that some key eHealth 
applications have had on strategic outcomes and 
can be used to perform also an exploratory analysis 
of this topic, from which we extract insights and 
recommendations for further work. This analysis 
was performed by developing different typologies, 
identifying distinct, yet homogeneous, groups. 
To this aim a Non-Hierarchical Cluster Analysis 
of K-means was applied. ANOVA test results 
showed that the means of contextual variables 
differed significantly across clusters. To attribute 
statistical significance to the differences obtained 
an associated Chi-square test was carried out.
Finally, we linked the eHealth deployment CI 
to external data on ICT expenditure on healthcare, 
on several indicator of healthcare output, and on 
indicator of health outcomes. This was performed 
at aggregate country level and must also be 
considered exploratory, yet as we show later such 
mapping produced meaningful and interesting 
result strongly suggesting that further work in this 
direction is worth pursuing.
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In this section we present all the results of 
the multivariate statistical analysis performed on 
the data from the survey, which we then further 
discuss in the next conclusive section. 
In § 4.1 we illustrate step by the step how 
the CI of eHealth deployment was constructed 
from the CIO’s answers to the questionnaire. We 
analyse each of the four dimensions identified (§ 
4.1.1 through § 4.1.4), and in doing so we can 
also transparently present the reader with the base 
indicators included under each dimension and 
the corresponding descriptive results. We also 
present for each dimension the factor analysis 
performed. As a result, in § 4.1.5 we illustrate the 
process followed to construct the CI and briefly 
comment the results. 
In § 4.2 we take the CI and map it against 
other data: a) other variables extracted from 
the survey such as the answers from MD 
reflecting usage of eHealth and hospitals 
structural characteristics (§ 4.2.1); b) data on 
country level aggregate expenditure for ICT in 
healthcare (§ 4.2.2); c) data on country level 
aggregate supply side healthcare indicators 
(§ 4.2.3). As stated earlier, this analysis can only 
be considered explorative given the aggregate 
level of data crossed against each other, on the 
basis of which it is important to stress that we 
will not attempt any causal attribution. This 
analysis enables us at the same time to test 
in a certain sense the robustness of CI (check 
any counterintuitive results) and to identify 
interesting direction for further research.
Finally in § 4.3 we analyse the answers 
provided by the Medical Directors on their 
perceptions of the impact of Electronic Patient 
and of Telemonitoring.
4.1 Hospitals' eHealth Deployment 
Composite Index
4.1.1 Infrastructure
More than 80% of the CIOs stated that their 
hospitals have a computer system connected to 
an Extranet or Internet connection through a value 
added network or proprietary infrastructure. More 
than half of the respondents (53.3%) reported 
that hospitals support wireless communication, 
while around 40% stated that hospitals have 
videoconference facilities and broadband above 
50MBps (see Table 2).
To confirm the several internal 
complementarities of the variables, the means 
and their significant correlation were checked.22 
Factor Analysis (henceforth simply FA) was 
performed on the individual variables included 
in the infrastructure dimension to identify 
common relationships among them (see Table 
3). This analysis yields two statistically significant 
and conceptually meaningful factors. The first 
22 See Table 53 in Annex 2.
Table 2: Infrastructure dimension: descriptive summary statistics
Computer system connected 81.5 (706)
Hospital support wireless communications 53.3 (442)
Broadband above 50 MBps 40.9 (371)
Hospital video conference facilities 39.1 (353)
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factor has salient loadings on the first two 
indicators (Computer system connected and 
Broadband above 50MBps). It may be interpreted 
as representing ‘Physical infrastructure’. The 
second factor has salient loadings on the 
last two indicators (wireless communication 
and videoconference facilities) and may be 
interpreted as representing ‘Services’ (i.e. services 
oriented infrastructure). Therefore, the items in 
each factor illustrated in the table below provide 
a fairly intuitive understanding of what we mean 
by the two labels assigned to the two factors: by 
‘physical’ we refer to the very basic infrastructure 
(computers connected and broadband), whereas 
support for wireless and video-conference are 
more related to the activities and the ‘services’ 
springing from them.
Using the identified factors as weights 
the four base indicators can be aggregated 
into a country level summary index of the 
infrastructure dimension (see Table 4 overleaf). 
The interpretation of these weights, which 
are obtained by squaring and normalising the 
estimated factor loadings, is straightforward. The 
squared factor loadings represent the proportion 
of the total unit variance of the indicator that is 
explained by factor. The resulting score by sub-
dimension can be aggregated into the summary 
indicator of ‘Infrastructure’ dimension according 
to its relative contribution to the explanation of 
the overall variance of the two factors: the first 
explains 39.9% of this variance, while the second 
factor explains 21.7% of it.
As for the Table 4 we can make the 
observation that all of the seven top scoring 
countries (including the Scandinavian and 
Nordic group, plus the UK a bit below) show 
a more marked emphasis on service-oriented 
infrastructure, that is ICT infrastructure more 
directly instrumental to the internal and external 
activities of the hospitals (wireless for internal 
mobile use of applications, videoconferences for 
Table 3: Infrastructure dimension: factor analysis
 Factor 1* Factor 2*
Interpretation
Infrastructure physical 
oriented
Infrastructure service 
oriented
 Commonalities
Factor 
loadings
Weights of 
variables in 
factor**
Factor 
loadings
Weights of 
variables in 
factor**
Computer system 
connected
.485 0.694 0.381 0.064 0.003
Broadband above
50 MBps
.564 0.746 0.441 0.085 0.006
Hospital support wireless 
communications
.856 -0.023 0.000 0.925 0.711
Hospital video conference 
facilities
.561 0.474 0.178 0.580 0.280
Weight of factors in 
summary indicators***
0.466 0.534
Selection criteria
Eigenvalues 1.596 .870
% Variance explained 39.905 21.756
Notes:  Rotated components matrix; Sampling method: factor analysis by main components; Rotation method: Varimax with Kaiser-
Meyer-Olkin 0.630; Bartlett’s test of sphericity p=0.000; Convergence in 3 itineration; Minimum eigenvalue 0.87.
* Based on rotated component matrix. 
** Normalised squared factor loadings. 
*** Normalised sum of squared factor loadings.
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external interactions). This finding seems in line 
with what is well known about both the general 
and health specific eReadiness level of these 
countries.
4.1.2 Applications and Integration
More than 70% of acute European hospitals 
have:
•	 Electronic Patient Record; 
•	 Integrated system for billing 
management; 
•	 Electronic appointment booking system;
•	 Electronic Clinical Tests. 
It is important to note that only 4% of hospitals 
provide their customer with online access to their 
health records, that is Personal Health Record 
Table 4: Infrastructure dimension countries index according to the estimated factors
Summary indicator
Dimension Sub-dimensions
Infrastructure
Infrastructure physical 
oriented
Infrastructure service oriented
DENMARK .913 .383 .530
ICELAND .913 .246 .530
IRELAND .913 .335 .530
FINLAND .887 .369 .519
SWEDEN .833 .287 .530
NORWAY .783 .383 .400
UK .745 .293 .431
AUSTRIA .705 .310 .385
NETHERLANDS .661 .294 .358
LUXEMBOURG .618 .315 .303
SPAIN .607 .275 .327
BELGIUM .604 .259 .341
BULGARIA .581 .248 .275
FRANCE .547 .232 .309
PORTUGAL .533 .238 .292
CROATIA .496 .383 .113
LATVIA .490 .187 .303
CZECH REPUBLIC .486 .213 .233
ITALY .462 .224 .230
CYPRUS .456 .159 .303
GERMANY .451 .242 .199
HUNGARY .390 .201 .189
MALTA .373 .196 .177
ROMANIA .320 .182 .110
SLOVENIA .313 .187 .127
GREECE .302 .198 .096
LITHUANIA .287 .255 .059
ESTONIA .253 .178 .227
POLAND .251 .080 .156
SLOVAKIA .135 .059 .127
See Annex 1. Measurement of dispersion – eHealth Deployment index by country for more detailed information. 
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(PHR) and only 8.7% provide Telemonitoring 
services. Among user oriented applications only 
eBooking (70.8%) seems to be quite widespread. 
So, at the aggregate level the clinical extramural 
orientation of eHealth applications in acute 
hospitals seems still limited (see Table 5). On the 
other hand, we must point out that an earlier 
exploratory cluster analysis we had performed 
identified a clear cluster of 100 hospitals where 
PHR and/or Telemonitoring were used.
PACS (61.7%), electronic clinical tests 
(70.7%), and an electronic service order 
placing (56%), which are application supporting 
professionals, are fairly widespread.
We proceeded in this case following exactly 
the same logic and procedure as we illustrated 
for the infrastructure dimension, which we will 
no longer repeat here and for the following 
dimensions. 
From FA (see Table 6) we derived weights 
used to construct a country level summary index 
of this dimension (see Table 7).
FA23 identified four meaningful factors, 
whose labels are abbreviated for reasons of space 
23 See Table 54 in Annex 2.
in the table. Factor 1 includes applications more 
directed to the professional side of core clinical 
activities such as: clinical tests; diagnostics results; 
PACS and teleradiology. Factor 2 captures an 
orientation to the patient for what concerns his/
her intramural management. Factor 3 concerns 
instead patients demand and safety. Finally, Factor 
4 captures items that we can take as a proxy of 
a more pronounced extramural orientation (i.e. 
telemonitoring).
The data in the table above tend to confirm 
the aggregate summary statistics impression that 
applications mainly supporting the work of the 
professionals are more widespread, for they tend 
to be more pronounced regardless of the overall 
ranking. On the other hand, top scoring countries 
clearly stand out in terms of more extramural 
orientation.24 
4.1.3 Information flows
CIOs were asked about whether their 
hospitals exchange electronically different types 
of information (clinical information; laboratory 
results; medical lists information and/or 
24 The earlier mentioned exploratory cluster analysis had 
identified a clear cluster of 100 hospitals where PHR and/
or Telemonitoring were used that were relatively more 
concentrated in the top scoring countries of this table.
Table 5: Application and integration dimension: descriptive summary statistics
Electronic Patient Record (EPR) 81.2 (736)
An integrated system for billing management 76.7 (695)
An electronic appointment booking system 70.8 (640)
An electronic Clinical Tests 70.7 (638)
Picture archiving and communication systems (PACS) 61.7 (557)
An electronic service order placing (e.g. test/diagnostic results) 56.0 (496)
An integrated system to send electronic discharge letters 42.1 (381)
An adverse health events report system 42.1 (354)
An integrated system for tele-radiology 40.0 (362)
An integrated system to send or receive electronic referral letters 33.8 (306)
A computerized system for ePrescribing 29.9 (271)
Tele-homecare/tele-monitoring services to outpatients (at home) 8.7 (77)
Personal Health Record (PHR) 4.4 (40)
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radiology reports) with different types of external 
actors (another hospital, general practitioners, 
specialists, healthcare providers in other EU or 
non EU countries). 
It is evident from the Table 8 that cross 
border electronic exchange of information 
is very limited: less than 5% of hospitals 
exchange information electronically with 
healthcare providers in other countries and not 
surprisingly, given the well known advanced 
development of teleradiology, the highest 
percentage of cross border electronic exchange 
concerns radiology reports. 
Table 7: Application and integration dimension countries index according to the estimated factors 
Summary indicator
Dimension Sub-dimensions
Application
Emphasis on 
clinical and 
image
Emphasis on 
EPR and patient 
management 
(intramural)
Emphasis on 
patient access 
and safety
Emphasis on 
PHR and tele 
monitoring 
(extramural)
SWEDEN .607 .230 .188 .139 .026
DENMARK .565 .222 .221 .076 .046
FINLAND .516 .222 .142 .125 .021
NETHERLANDS .506 .173 .170 .139 .020
BELGIUM .496 .200 .161 .122 .011
NORWAY .466 .187 .139 .127 .013
SPAIN .448 .181 .128 .122 .018
PORTUGAL .446 .185 .137 .110 .014
UK .441 .199 .132 .101 .011
ESTONIA .433 .190 .187 .113 .000
ICELAND .429 .161 .199 .069 .000
LUXEMBOURG .426 .190 .093 .143 .000
IRELAND .424 .180 .082 .139 .023
AUSTRIA .389 .180 .110 .098 .000
HUNGARY .365 .151 .117 .073 .028
CYPRUS .364 .137 .139 .113 .000
MALTA .354 .197 .069 .087 .000
CROATIA .346 .093 .120 .121 .012
ITALY .343 .150 .074 .103 .018
CZECH REPUBLIC .338 .175 .083 .071 .000
SLOVAKIA .326 .135 .082 .057 .015
GREECE .312 .071 .127 .102 .006
GERMANY .286 .137 .053 .098 .001
FRANCE .285 .074 .095 .107 .010
LATVIA .284 .123 .104 .057 .000
POLAND .231 .093 .068 .065 .005
LITHUANIA .221 .092 .072 .057 .000
BULGARIA .194 .077 .069 .036 .009
SLOVANIA .142 .054 .036 .052 .000
ROMANIA .123 .067 .060 .024 .005
See Annex 1. Measurement of dispersion – eHealth Deployment index by country for more detailed information. 
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A third of the respondents (32.8%) stated that 
their hospitals exchange electronically clinical 
information with a hospital or hospitals outside 
their own system; 28% stated that their hospital 
exchange clinical information with external 
specialists and 27.6% with external general 
practitioners. 
In addition to clinical information, CIOs were 
asked about laboratory results: 30.1% of hospitals 
exchange this kind of information with a hospital 
or hospitals outside their won system; around a 
quarter of them also exchange electronically this 
information with external general practitioner 
(26.8%) and with external specialists (23.6%). 
Electronically exchange of medication list 
information with external general practitioners 
is reported by 13.7% of the CIOs; almost the 
same proportion reported that their hospital 
exchange this type of information with a hospital 
or hospitals outside their own system (13%) and 
with external specialists (12%). The exchange 
of this information with healthcare providers in 
other countries is less than 3%.
Finally, more than 25% of the CIOs stated 
that their hospitals electronically exchange 
radiology reports with a hospital or hospitals 
outside their own system (33.9%); with external 
specialists (28.1%) and with external general 
practitioners (24.6%). 
In addition to the general comment on the 
limited cross border electronic exchange we can 
also point out that such exchanges with primary 
care (general practitioners) is not as widespread 
as it could, especially for certain items. This data 
actually confirms the well-known bottleneck for 
the development of ICT supported integrated 
Table 8: Information flows dimension: descriptive summary statistics
Clinical Information
With a hospital or hospitals outside your own hospital system 32.8 (297)
External specialists 28.0 (254)
External general practitioners 27.6 (250)
Healthcare providers in other EU countries 4.6 (42)
Healthcare providers outside the EU countries 2.1 (19)
Laboratory results
With a hospital or hospitals outside your own hospital system 30.1 (273)
External general practitioners 26.8 (243)
External specialists 23.6 (214)
Healthcare providers in other EU countries 3.8 (34)
Healthcare providers outside the EU countries 1.7 (15)
Medication lists information
External general practitioners 13.7 (124)
With a hospital or hospitals outside your own hospital system 13.0 (118)
External specialists 12.0 (109)
Healthcare providers in other EU countries 2.2 (20)
Healthcare providers outside the EU countries 1.0 (9)
Radiology reports
With a hospital or hospitals outside your own hospital system 33.9 (307)
External specialists 28.1 (255)
External general practitioners 24.6 (223)
Healthcare providers in other EU countries 4.4 (40)
Healthcare providers outside the EU countries 2.3 (21)
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healthcare represented by the sub-optimal 
collaboration between different healthcare tiers.
FA25 of the individual variables within the 
Information flow dimension yields four factors 
25 See Table 55 in Annex 2.
(see Table 9). Factor 1 relates to electronically 
exchange of information across countries within 
and outside EU boundaries. Factor 2 is about 
information flow among doctors.  Factor 3 
identifies a drugs oriented focus of electronic 
exchange, and finally Factor 4 captures 
information flows between Hospitals. 
Table 10: Information flows dimension countries index according to the estimated factors 
Summary indicator
Dimension Sub-dimensions
Information 
flows
Country
Health 
professionals
Medication list Hospital
NORWAY .415 .051 .214 .088 .062
UK .295 .039 .146 .045 .064
BELGIUM .286 .016 .195 .020 .055
IRELAND .283 .089 .122 .018 .054
DENMARK .277 .007 .157 .040 .073
NETHERLANDS .273 .035 .152 .037 .049
SWEDEN .234 .011 .119 .049 .055
SPAIN .212 .014 .121 .023 .054
AUSTRIA .211 .000 .129 .036 .046
FINLAND .205 .003 .089 .028 .084
LATVIA .201 .103 .066 .000 .031
ESTONIA .184 .000 .132 .000 .052
ICELAND .148 .000 .078 .048 .021
LUXEMBOURG .148 .000 .094 .012 .042
SLOVAKIA .141 .026 .077 .006 .032
CYPRUS .120 .050 .041 .013 .015
MALTA .111 .000 .080 .000 .031
CZECH REPUBLIC .104 .003 .062 .002 .037
ITALY .098 .013 .046 .012 .027
HUNGARY .087 .000 .053 .000 .034
LITHUANIA .078 .024 .036 .000 .019
FRANCE .075 .000 .043 .011 .021
SLOVENIA .075 .000 .054 .000 .021
GERMANY .071 .000 .040 .008 .023
PORTUGAL .063 .002 .029 .005 .026
ROMANIA .059 .012 .028 .005 .014
CROATIA .046 .000 .038 .000 .008
POLAND .037 .012 .015 .002 .008
GREECE .018 .007 .000 .004 .007
BULGARIA .000 .000 .000 .000 .000
See Annex 2. Measurement of dispersion – eHealth Deployment index by country for more detailed information. 
40
4 
R
es
ul
ts
It is worth noting, as could be expected 
from the comment to the descriptive statistics 
presented earlier (§ 4.1.2, about limited diffusion 
of extramural applications), that we found 
not factors concerning a focus on electronic 
exchange of patient centred data and/or on 
exchanges between hospitals and the patients 
themselves.
Table 11: Security and privacy dimension: descriptive summary statistics
Protect the patient data Workstations with access only through a password 93.2 (844)
Security and privacy of electronic patient data at national level 62.8 (529)
Protect the patient data Encryption of all transmitted data 62.7 (568)
Protect the patient data Encryption of all stored data 38.3 (347)
Security and privacy of electronic patient data at regional level 36.3 (329)
Protect the patient data Data entry certified with digital signature 28.6 (259)
Protect the patient data Workstations with access only through health professional cards 19.3 (175)
Protect the patient data Workstations with access only through fingerprint information 4.1 (37)
Table 12: Security and privacy dimension: factor analysis
Factor 1* Factor 2* Factor 3*
Interpretation
Emphasis on  
encryption 
Emphasis on regulation
Emphasis on 
workstation
Commona-
lities
Factor 
loadings
Weights of 
variables 
in factor**
Factor 
loadings
Weights of 
variables 
in factor**
Factor 
loadings
Weights of 
variables 
in factor**
Protect the patient data 
Encryption of all stored 
data
.727 0.849 0.521 0.047 0.002 0.061 0.003
Protect the patient 
data Encryption of all 
transmitted data
.668 0.789 0.450 0.177 0.023 0.118 0.011
Security and privacy of 
electronic patient data at 
national level
.707 0.14 0.014 0.829 0.499 0.004 0.000
Security and privacy of 
electronic patient data at 
regional level
.652 0.078 0.004 0.784 0.447 0.179 0.026
Protect the patient data 
Workstations with access 
only through health 
professional cards
.708 0.061 0.003 -0.021 0.000 0.839 0.569
Protect the patient data 
Data entry certified with 
digital signature
.537 0.108 0.008 0.201 0.029 0.696 0.391
Weight of factors in 
summary indicators***
0.350 0.340 0.310
Selection criteria
Eigenvalues 1.981 1.017 1.002
% Variance explained 33.013 16.947 16.707
Notes: Rotated components matrix; Sampling method: factor analysis by main components; Rotation method: Varimax with Kaiser-
Meyer-Olkin 0.667; Bartlett’s test of sphericity p=0.000; Convergence in 4 itineration; Minimum eigenvalue 1.
* Based on rotated component matrix.
** Normalised squared factor loadings.
*** Normalised sum of squared factor loadings.
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As per the country ranking (see Table 10), 
produced by using factors as weights to construct 
a summary index for this dimension, we can notice 
that at least in the top scoring countries cross border 
exchanges seem to be a bit more important.
4.1.4 Security and privacy
The use of password to access workstation 
within the hospital to protect patient data is 
established in almost all the hospitals (93.2%). 
Other security measures such as digital signature 
(28.6%), health professional cards (19.3%), or 
fingerprints information (4.1%) are less spread 
among hospitals. Two thirds of CIOs stated that all 
transmitted data are encrypted and that they follow 
national level regulation to guarantee the security 
and privacy of electronic patient medical data. 
One third stated that all stored data are encrypted 
and that regional level regulation is followed (see 
Table 11).
The factor analysis on the individual variables 
included in the Security and Privacy dimension 
yield three factors (see Table 12). Factor 1 is about 
Encryption, Factor 2 about Regulation, and Factor 
3 about Workstation.
As per the country ranking (see Table 13), 
produced by using factors as weights to construct 
a summary index for this dimension, we can 
notice that some countries scoring consistently 
at the top in the other three dimensions seem to 
place relatively less emphasis on security and 
privacy issues (i.e. Denmark and Norway).
4.1.5  The Composite Index
The Hospital eHealth Deployment CI 
has been developed following a multistage 
approach [60, 62], which is graphically 
rendered in Figure 6. 
Figure 6: eHealth deployment composite index construction
Source: Authors’ elaboration.
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At this point, partially recalling what 
anticipated in Section 3, it is worth recalling the 
various steps involved:
1. Collection and preparation of the basic 
data.
2. Conceptual identification of the four 
dimensions and inclusion in them of the 
base indicators (the lowest level variable 
resulting from answers to each of the 
questionnaire questions).
3. Definition of the detailed indicators, 
which constitute the basis for subsequent 
estimation.
4. Estimation of the summary index for 
each dimension and sub-dimension. 
5. Estimation of the overall CI, which 
summarises the features of the various 
dimensions and sub-dimensions 
summary indexes and provides the 
most synthetic measure of eHealth 
Deployment.
Table 13: Security and privacy dimension countries index according to the estimated factors 
Summary indicator
Dimension Sub-dimensions
Security and 
Privacy
Encryption Regulation Workstation
UK .671 .262 .248 .161
ESTONIA .645 .227 .220 .198
IRELAND .583 .271 .281 .030
SWEDEN .583 .190 .260 .134
ICELAND .544 .174 .271 .099
SPAIN .522 .200 .224 .098
NORWAY .493 .187 .254 .052
AUSTRIA .490 .222 .193 .075
DENMARK .468 .147 .208 .113
PORTUGAL .464 .141 .218 .104
ROMANIA .437 .253 .136 .049
ITALY .434 .156 .177 .100
NETHERLANDS .431 .160 .210 .061
GERMANY .418 .187 .179 .052
FRANCE .398 .173 .147 .079
FINLAND .359 .112 .180 .067
BELGIUM .355 .165 .107 .083
CZECH REPUBLIC .289 .167 .098 .024
POLAND .275 .158 .089 .028
HUNGARY .268 .102 .166 .000
LUXEMBOURG .259 .053 .107 .099
MALTA .224 .053 .113 .059
LITHUANIA .211 .052 .117 .042
GREECE .184 .032 .134 .018
CROATIA .173 .131 .042 .000
SLOVANIA .172 .000 .113 .059
SLOVAKIA .170 .113 .042 .015
CYPRUS .148 .000 .104 .044
BULGARIA .061 .045 .000 .016
LATVIA .057 .000 .057 .000
See Annex 2. Measurement of dispersion – eHealth Deployment index by country for more detailed information.
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Whereas the completion of steps 2 and 3 two 
steps entailed some conceptual and theoretical 
judgement, the fourth step was entirely based 
on multivariate analysis and the fourth step 
complements the multivariate analysis assuming 
that each dimension is equalled weighted so 
the effect of the number of variables included 
in each dimension does not influence the final 
result (as weights have been applied in previous 
steps). The  choice of weighting equally the four 
dimensions was explicitly made and illustrated 
with regard to sound reasoning as illustrated in § 
3.3. Furthermore, to be fully transparent we have 
developed Table 14 and 15 summarising the final 
weights that have been used for each one of the 
basic indicator: 
Table 14: Construction of the detailed indicators
Categorical data
Overall weight 
dimensions
Dimension Sub-dimension
Weight of 
factors in 
summary 
indicators*** 
Sub-
dimension 
Weights 
of 
variables 
in 
factor**
Computer system connected
0.25 Infrastructure
Infrastructure physical 
oriented
0.466
0.381
Broadband above 50 MBps 0.441
Hospital support wireless 
communications Infrastructure service 
oriented
0.534
0.711
Hospital video conference 
facilities
0.28
Picture archiving and 
communication systems 
(PACS)
0.25
Application 
and
Integration
Emphasis on clinical and 
image
0.314
0.294
An integrated system for
tele-radiology
0.242
An electronic Clinical Tests 0.11
An electronic service order 
placing? (e.g. test/diagnostic 
results)?
0.121
An integrated system to send 
electronic discharge letters
Emphasis on EPR and 
patient management 
(intramural)
0.296
0.231
An integrated system to send 
or receive electronic referral 
letters
0.223
A computerized system for 
ePrescribing
0.171
Electronic Patient Record (EPR) 0.122
An integrated system for billing 
management
Emphasis on patient 
demand and safety
0.212
0.37
An electronic appointment 
booking system?
0.165
An adverse health events 
report system
0.139
Tele-homecare/tele-monitoring 
services to outpatients Emphasis on PHR and tele 
monitoring (extramural)
0.178
0.509
Personal Health Record (PHR) 0.278
** Normalised squared factor loadings.
*** Normalised sum of squared factor loadings.
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Categorical data
Overall 
weight 
dimensions
Dimension Sub-dimension
Weight of 
factors in 
summary 
indicators*** 
Sub-
dimension 
Weights 
of 
variables 
in 
factor**
Laboratory results Healthcare providers 
outside the EU countries
0.25
Information 
flow
Country 0.413
0.149
Radiology reports  Healthcare providers 
outside the EU countries
0.136
Clinical information: Healthcare providers 
outside the EU countries
0.126
Medication lists information Healthcare 
providers outside the EU countries
0.122
Laboratory results Healthcare providers in 
other EU countries
0.12
Radiology reports  Healthcare providers in 
other EU countries
0.116
Clinical information: Healthcare providers in 
other EU countries
0.104
Medication lists information Healthcare 
providers in other EU countries
0.096
Laboratory results External specialists
Health professionals 0.309
0.14
Laboratory results External general 
practitioners
0.137
Radiology reports  External general 
practitioners
0.136
Clinical informacion: External general 
practitioners
0.131
Clinical information: External specialists 0.119
Radiology reports  External specialists 0.118
Medication lists information External 
specialists
Medication list 0.146
0.255
Medication lists information External general 
practitioners
0.252
Medication lists information With a hospital or 
hospitals outside your own hospital system
0.231
Radiology reports With a hospital or hospitals 
outside your own hospital system
Hospital 0.131
0.257
Clinical information: With a hospital or 
hospitals outside your own hospital system
0.226
Laboratory results With a hospital or hospitals 
outside your own hospital system
0.224
Protect the patient data Encryption of all stored 
data
0.25
Security
and
Privacy
Emphasis on  
encryption 
0.35
0.521
Protect the patient data Encryption of all 
transmitted data
0.45
Security and privacy of electronic patient data 
at national level Emphasis on 
regulation
0.34
0.499
Security and privacy of electronic patient data 
at regional level
0.447
Protect the patient data Workstations with 
access only through health professional cards Emphasis on 
workstation
0.31
0.569
Protect the patient data Data entry certified 
with digital signature
0.391
** Normalised squared factor loadings.
*** Normalised sum of squared factor loadings.
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 Finally, the next two figures present the 
results of this process, Figure 7 the CI and Figure 8 
the same CI together with the dimension specific 
summary indexes.
At this point looking at the overall results the 
traditional questions arise: does it make sense 
with respect to general background knowledge? 
Do the differences among countries and between 
each country and the EU27 average make sense? 
Does the CI make justice with respect to countries 
peculiarities?
First, at a strictly technical level, the answer is 
that the sample is statistically representative of the 
universe of acute hospitals in each countries, the 
questions were fully explained and understood by 
the respondents, the methodology followed and 
transparently illustrated is sound and not based on 
any hidden arbitrary choice, a sensitivity analysis 
(changing the weights of the four dimensions) 
confirmed the technical robustness of the CI.  So, 
we could simply reply that this is what the data 
tell us.
Second, the value of the CI index can be 
checked against other country level variables to 
see whether it makes sense (i.e. higher level of 
ICT spending in healthcare should be reflected 
in higher score in the CI). We do this substantive 
robustness check in next paragraph.
Third we can attempt to make some 
considerations with respect to what is known 
about countries eReadiness in general and about 
their eHealth strategies trajectories [11].  
With respect to general eReadiness we 
find that the results below the average toward 
the bottom and above the average make perfect 
sense.26 Countries just below or above the average 
may raise some questions and particular the 
relatively low ranking of three big countries such 
as Italy, France, and Germany. In this respect we 
must first point out that the larger the countries 
26 With the possible surprise of the Ireland where, however, 
eHealth national efforts have been sustained in recent 
years [11].
Figure 7: Hospitals' eHealth Deployment Composite Index: country ranking
See Annex 2. Measurement of dispersion – eHealth Deployment index by country for more detailed information. 
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the higher was the statistical representativeness of 
the sample, which in our view rules out a possible 
biased sample explanation. Furthermore, we can 
anticipate that the background variables used in 
next paragraph are aligned in relative terms to such 
result for these three countries.  Finally, the low 
ranking of these three countries can be partially 
explained by their eHealth strategy trajectory [11].
What is more interesting to consider from the 
policy perspective, however, are the value of the 
CI in general and by country and also how it can 
be broken down into the four dimensions (Figure 
8). From these values key policy messages can 
be taken away. Below we only make some very 
brief and general comment, for we will discuss key 
policy messages in more details in Section 5. 
The CI average EU27 value is below 0.5, 
which means that a lot of progress should still 
be made and that this index could be used for 
quite some time in the coming years before it will 
become saturated (even top scoring countries are 
just above 0.5).  There is quite some nice variability 
among countries that could be further studies 
and explored in the future crossing the CI with 
qualitative evidence and with other quantitative 
variables (in more granular fashion than those we 
used in next paragraph). 
Looking at the different summary indexes of 
the four dimensions it is clear that infrastructure 
is the domain where more progress has been 
achieved, whereas electronic information flows 
and exchange lag behind.  Application and 
Integration tend to be relatively well developed 
and come second after infrastructure, although in 
some countries security and privacy issues seem 
to be prioritised over integrated applications (a 
fact probably deserving some further qualitative 
country specific analysis). 
4.2 Validation: explorative mapping of the 
composite index against other data
A literature search was carried out to identify 
external standard that could be used to asses the 
criterion validity of the CI. Due to the absence 
of such a standard, following Otieno et al. [63] 
Two types of correlation analysis were performed. 
Firstly, One-Way Analysis of Variance (ANOVA) 
was carried out with our CI as a dependent variable 
and a list of applications reported by Medical 
Directors as factors. The same analysis was carried 
out considering the characteristics of the hospitals 
(number of beds, structure of property, etc). Both 
analyses used data gathered in our survey and 
were performed at a hospital level. Secondly, 
a more exploratory analysis were developed 
considering external factors as ICT healthcare 
expenditure per capita and other supply side 
healthcare indicators. To enrich our validation, the 
analysis was performed at a country level. 
4.2.1 Mapping the CI against other survey data
As explained, in 280 hospitals also Medical 
Directors (MD) were surveyed and asked, among 
other things, whether some eHealth applications 
were actually used by the medical staff under their 
supervision (see summary statistics in Table 16).
Table 16: Utilisation of eHealth applications by medical staff
Picture Archiving and Communication System (PACS) 67.6
Electronic order communication system for laboratory exams 62.9
Electronic patient record system common to most of the departments 59.9
eAppointment system 54.0
Electronic system to send and receive referral letters 49.6
ePrescription 39.4
Electronic system to send discharge letters to general practitioners 32.6
Videoconferencing for consultation 30.0
Telemonitoring of outpatients at home 8.3
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The Table 16 can be interpreted as follows 
(base on one illustrative item only): 67.6% of the 
280 MD reported that their medical staff used 
PACS in daily work activities. Since MD answers 
could be matched to hospitals and thus compared 
with CIOs ones, for a subset of 280 hospitals it 
was possible to correlate the CI with the level of 
usage of application by medical staff.
One-Way Analysis of Variance (ANOVA) was 
carried out with eHealth Hospital Deployment CI 
as a dependent variable and a list of applications 
reported by Medical Directors as factors. All 
factors were statistically significant and reveal 
a positive relationship between the composite 
index and the utilisation of each application. 
This is a very meaningful result as it tells us that 
the CI is higher in those hospitals where usage 
of eHealth application is more intense. In other 
words hospitals invest more in eHealth (and have 
higher CI) where eHealth is actually used. So, 
from this first check point the CI seems to come 
out corroborated. Although it must be stressed, 
however, that this check has been done using the 
hospitals and not the countries as unit of analysis 
(280 hospitals only did not allow us to do a robust 
country level analysis).
The same analysis, yielding equally 
comforting results, was replicated correlating 
the CI with variables characterising the hospitals 
(number of beds, structure of property, etc). One-
Way Analysis of Variance (ANOVA) was carried 
out with eHealth Hospital Deployment index as a 
dependent variable and Hospital’s characterisation 
as factors. All factors were statistically significant 
(see Figure 11). There is a trend showing a positive 
relationship between our index and: ownership 
of the Hospital (public or private not for profit); 
number of beds; structure of the Hospital (part of 
a group of different hospitals or part of a group 
of care institutions); computer system externally 
connected; application integrated in your 
Hospitals and computer system.
Figure 9: Hospitals' eHealth Deployment CI and application usage
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4.2.2 Mapping the CI against country-level ICT 
per capita spending in healthcare
After mapping our CI against “ICT spending 
in Health per capita” data from WITSA [47] we 
get the very interesting explorative association 
conveyed by the Figure 12.
Countries with more intensive (per capita) 
healthcare spending in ICT score higher in our 
hospitals eHealth Deployment CI and it seems 
now perfectly sound that Italy, France and 
Germany have lower than expected CI in view of 
the fact that their ICT expenditure is considerably 
less intensive than in countries such as for 
instance Denmark, Sweden, and Norway.
The data used are too aggregate and 
we do not dare going further than simply 
pointing out a mere statistical association. 
Figure 10: Hospitals' eHealth Deployment CI and application usage
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Yet, at least the direction is comforting: if it 
was negative (high rank in CI associate with 
low level of spending intensity) than we 
might have had a problem. 
4.2.3 Mapping the CI against country level 
supply side healthcare indicators
We replicated the operation done with ICT 
expenditure in healthcare with the following 
Figure 11: Hospitals' eHealth Deployment CI and characterising factors
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supply side indicators:27 “Hospital beds - Per 
100,000 of population” (see Figure 13); “Practising 
physicians - Per 100,000 of population” (see 
Figure 14); “Number of Computer tomography 
scanners per 100,000” (see Figure 15).
Again we stress that our aim was 
explorative and we looked for mere trends 
and statistical associations, with no claim to 
demonstrated significant statistical correlations 
and even less so infer causal relation. Yet, all 
of the trends illustrated in the following figures 
are comforting and not counterintuitive with 
respect to what one would expect as a result of 
wide introduction of eHealth on the above three 
supply side indicators: a) it would be counter-
27 Data were downloaded from Health in Europe: 
Information and Data Interface (HEIDI) developed by 
Directorate General for Health and Consumers http://
ec.europa.eu/health/indicators/indicators/index_en.htm. 
We have utilised the last year available 2008.
intuitive and challenging to find the our CI is 
higher in countries with the highest number of 
hospital beds; b) it would be counter-intuitive 
and challenging to find the our CI is higher in 
countries with the lowest number of practicing 
physicians; c) it would be counter-intuitive 
and challenging to find the our CI is higher in 
countries with the highest number of computer 
tomography scanners.  The trends in the figures 
do not support such instances. Naturally, we 
do not claim that having a higher CI enable to 
use fewer beds, to support more physicians, 
and to substitute scanners, for a much more in 
depth and granular analysis would be needed 
to substantiate this hypothesis. We simply 
observe that at least the direction of the trend 
is in line with what one may expect from 
relatively higher deployment of eHealth in 
hospitals. 
Figure 12: Hospitals' eHealth Deployment CI and ICT expenditure per capita in healthcare
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ts Figure 13: Hospitals' eHealth Deployment CI and number of hospital beds per 100,000
Figure 14: Hospitals' eHealth Deployment CI and number of practising physicians per 100,000
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4.3 eHealth impacts: The view of 
medical directors
Medical directors were asked their views 
on the actual and potential impacts that having 
Electronic Patient Records (EPRs) and providing 
telemonitoring services at home have had or 
could have on a number of desirable outcomes. 
Below we first report the summary statistics on 
MD answers and then perform a factor and cluster 
analyses separately for EPRs and Telemonitoring.
Please note that, whereas the answer of CIOs 
could be taken as objective sources of information 
about the hospitals, the same cannot be applied 
to the MD answers on impacts. They represent, 
in fact, the perception of individuals and, thus, 
the factor and cluster analyses concern mostly 
the MD and cannot be taken as representing the 
factual situation of hospitals (although certainly 
such perceptions are shaped by such situation). 
Accordingly, we did not attempt any correlation 
between the results of the factor and cluster 
analysis on MD perception of impacts and the 
hospitals CI, although it would have certainly 
been of great interest to test whether perception 
on impact was in any way correlated with the level 
of eHealth deployment in hospitals. Nonetheless 
the results of the factor and cluster analysis are 
quite interesting and suggest important directions 
for future research.
4.3.1 Descriptive statistics
More than a half of the surveyed MD agreed 
with the positive impacts that the use of EPR 
systems may have had on: a) the reduction of 
waiting lists; b) the average number of patients the 
hospital can admit; and c) the amount of waste 
linked to unnecessary repetition of examinations. 
So, it seems that in the eyes of the MD the EPRs 
have a positive effects on what we can call 
operational outcomes (see Table 17).
One the other hand, however, more 
than 75% of Medical Directors do not think 
Figure 15: Hospitals' eHealth Deployment CI and number of scanners per 100,000
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Totally 
disagree
Somewhat 
disagree
Somewhat 
agree
Totally 
agree
Medical errors have been reduced 27.7 (43) 58.7 (91) 7.7 (12) 5.8 (9)
The quality of diagnosis decisions has improved 31.3 (50) 43.1 (69) 16.3 (26) 9.4 (15) 
The quality of treatment decisions has improved 25.5 (41) 49.7 (80) 13.7 (22) 11.2 (18)
The working processes of medical staff are more efficient 40.7 (68) 43.7 (73) 10.8 (18) 4.8 (8)
Waiting lists have been reduced 15.2 (23) 30.5 (46) 29.1 (44) 25.2 (38)
Average number of patients your hospital can admit during one day 
has been increased
13.1 (21) 29.4 (47) 25.6 (41) 31.9 (51)
The amount of waste linked to unnecessary repetition of 
examinations has diminished
27.2 (43) 41.8 (66) 19.6 (31) 11.4 (18)
Table 18: Telemonitoring impacts: MD perceptions
Not at all Not much
Some 
extend
Great 
extend
Reduction in time for achieving therapy stabilization 29.8 (78) 40.8 (107) 20.2 (53) 9.2 (24)
Improvement in the quality of life of patients 42.0 (113) 38.7 (104) 13.8 (37) 5.6 (15)
Reduction in the numbers and length of hospital stays 39.0 (105) 39.0 (105) 12.3 (33) 9.7 (26)
Reduction in medical errors 15.3 (40) 36.0 (94) 27.2 (71) 21.5 (56)
Improvement in the quality of diagnosis decisions 19.0 (51) 43.3 (116) 27.6 (74) 10.1 (27)
Improvement in the quality of treatment decisions 24.9 (68) 42.1 (115) 22.3 (61) 10.6 (29)
More efficient working processes among medical staff 36.3 (97) 37.5 (100) 19.5 (52) 6.7 (18)
Shorter waiting lists 30.0 (80) 37.1 (99) 18.0 (48) 15.0 (40)
Increased average number of patients receiving help during
one day
31.6 (84) 30.8 (82) 22.9 (61) 14.7 (39)
Table 19: MD perceptions on EPRs impacts: factor analysis
Factor 1. 
Emphasis 
on quality 
impact
Factor 2. 
Emphasis on 
throughput 
impact
Commonalities
Medical errors have been reduced .661 .185 .471
The quality of diagnosis decisions has improved .859 .117 .752
The quality of treatment decisions has improved .813 .156 .685
The working processes of medical staff are more efficient .625 .185 .424
Waiting lists have been reduced .059 .810 .660
Average number of patients your hospital can admit during one day 
has been increased
.198 .836 .737
The amount of waste linked to unnecessary repetition of examinations 
has diminished
.379 .559 .455
Auto values 3.038 1.147
% Variance explained 43.399 16.384
Notes: Rotated components matrix; Sampling method: factor analysis by main components; Rotation method: Varimax with Kaiser-
Meyer-Olkin 0.721; Bartlett’s test of sphericity p=0.000; Convergence in 3 itineration; Minimum eigenvalue 1.
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that an EPR systems has impact on more 
clinical and strategic patient outcomes such 
as: a) the reduction of medical errors; b) the 
improvement of quality of diagnosis; c) the 
quality of treatment decisions.
Although the specific impacts 
considered change, the situation emerging 
for Telemonitoring it is exactly the same 
as per EPRs (see Table 18). MDs perceive 
only the contribution of Telemonitoring to 
operational outcomes but not to clinical 
and patient strategic ones. The highest 
proportion of Medical Directors disagreed that 
Telemonitoring would: a) improve the quality 
of life of patients; b) result in a reduction in 
the number and length of hospital stays; and/
or c) result in more efficient working processes 
among medical staff. 
4.3.2 EPRs and telemonitoring impact: factor 
and cluster analysis
A factor analysis was undertaken to 
identify common relationships between the 
possible impacts that the use of EPR systems 
may have had in hospitals. From the analysis 
two factors emerged: (1) ‘emphasis on quality 
impact’ and (2) ‘emphasis on throughput 
impact’ (see Figure 19). In order to develop a 
typology of Medical Directors’ perception of 
impacts, a Non-Hierarchical Cluster Analysis 
of K-means was undertaken to these factors 
(see Table 20). These factors were selected 
due to their significance (p <.001) within the 
cluster analysis (See Table 56 in Annex).
Cluster one (46%, the overwhelming 
majority) consists of Medical Directors that place 
emphasis neither on quality nor on throughput. 
They see no impact at all and we labelled them 
‘Laggards’ only on the basis of a theoretical 
intuition that will need to be further tested with 
additional empirical evidence. If they perceive 
no impacts this may be due to personal and/or 
hospital characteristics: a) The MDs themselves 
have a conservative (negative) attitude toward the 
deployment and usage of eHealth in the hospitals; 
b) the MDs work in hospitals where eHealth 
applications have been introduced without the 
complementary organisational changes and, thus, 
they objectively see no impacts.
Cluster four, being the exact opposite of 
cluster one, include those MDs (22%) who 
perceive both kind of impacts (throughput and 
quality) and we called them the ‘transformers’, 
again on the basis of a theoretical intuition that 
will need to be further tested. If they perceive 
both impacts this may be due to personal and/
or hospital characteristics: a) The MDs themselves 
are enthusiast of eHealth deployment and usage 
in the hospitals; b) the MDs work in hospitals 
where eHealth applications have been introduced 
with the needed complementary organisational 
changes and, thus, they objectively see the 
impacts.
These two clusters set a continuum in a 
way that makes perfect sense with the main 
theoretical and empirical evidence from the 
general field of the economics of ICT. Within 
this continuum the other two clusters are 
Table 20: MD perceptions on EPRs impacts: cluster analysis
Clusters
Laggards 
42% (56) 
Rationalisers  
25% (34)
Experimenters    
11% (15)
Transformers
22% (30)
ANOVA F
Factor 1. Emphasis on quality 
impact
-.44202 -.65140 1.98303 .57184 103.221*
Factor 2. Emphasis on 
throughput impact
-.82912 1.04553 -.37188 .54869 80.222*
*p<.001 
Notes: Results of K-means - quick cluster analysis. Method of analysis: non-hierarchical cluster. Final cluster centroids.
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less clear cut but still meaningful. Cluster 
two (25%) includes those MD who perceive 
‘throughput impact’ but not ‘quality impact’. 
We called them rationalisers in the sense that, 
either only at intentional /subjective level or 
on the basis of factual experience, they see in 
eHealth applications only a way of achieving 
efficiency outcomes but are sceptical about 
clinical or patient strategic outcomes. Cluster 
three (11%) includes those MD who do not 
perceive ‘throughput impact’ but do perceive 
‘quality impact’. Contrary to the rationalisers, 
either only at intentional /subjective level or 
on the basis of factual experience, they see 
eHealth applications mainly as an instrument 
to increase quality and seem less concerned 
with efficiency. We called them, thus, the 
‘experimenter’ in that they might have gone 
into patient and quality oriented applications 
without having first introduced operational 
and efficiency oriented tools.  
The exact same factor and cluster analysis 
was applied to MDs answers on Telemonitoring 
impact and yielded statistically significant factors 
and cluster along the same line of what emerged 
for EPRs.  From the analysis two factors emerged: 
(1) ‘emphasis on quality impact’ and (2) ‘emphasis 
on throughput impact’ (see Table 21). In order 
to develop a typology of Medical Directors’ 
perception of impacts, a Non-Hierarchical 
Cluster Analysis of K-means was undertaken to 
these factors (see Table 22). These factors were 
Table 21: MD perceptions on telemonitoring impacts: factor analysis
Factor 1. 
Emphasis on 
throughout 
impact
Factor 2. 
Emphasis on 
quality impact
Commonalities
Improvement in the quality of life of patients .632 .373 .538
Reduction in the numbers and length of hospital stays .690 .363 .608
Reduction in medical errors .152 .768 .613
Improvement in the quality of diagnosis decisions .226 .877 .820
Improvement in the quality of treatment decisions .296 .846 .803
More efficient working processes among medical staff .645 .350 .539
Shorter waiting lists .824 .091 .686
Increased average number of patients receiving help during one day .813 .103 .672
Auto values 4.084 1.195
% Variance explained 51.046 14.943
Notes: Rotated components matrix; Sampling method: factor analysis by main components; Rotation method: Varimax with Kaiser-
Meyer-Olkin 0.842; Bartlett’s test of sphericity p=0.000; Convergence in 3 itineration; Minimum eigenvalue 1.
Table 22: MD perceptions on telemonitoring impacts: cluster analysis
Clusters
Laggards 
46% (105)
Rationalisers
19% (43)
Experimenters
17% (40)
Transformers
18% (42)
ANOVA F
Factor 1. Emphasis on throughout 
impact
-.55736 .83544 -.72465 1.22821 142.466*
Factor 2. Emphasis on quality 
impact
-.40519 -1.05507 1.28131 .87288 170.231*
*p<.001 
Notes: Results of K-means - quick cluster analysis. Method of analysis: non-hierarchical cluster. Final cluster centroids.
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selected due to their significance (p <.001) within 
the cluster analysis (See Table 57 in Annex).
Cluster one (46%) includes the ‘laggards’, 
cluster two (19%) includes the ‘rationalisers’, 
cluster three (17%), includes the ‘experimenters, 
and cluster four (18%) includes the transformers’.
4.3.3 Making sense of perceptions on impacts: 
the need for further data
As anticipated, technical data conditions do 
not allow us to correlate these two typologies 
with the Hospitals eHealth Deployment CI. 
We tested the extent to which such typologies 
are correlated with hospitals characteristics 
(size, forms of property, etc) and we found no 
statistically significant relation.
The most important and interesting result is 
that, going beyond the main aggregate message 
coming from descriptive statistics (MD tend to 
perceive little impact), there are clearly significant 
differences if factor and cluster analysis are 
applied. These differences envisage potentially 
very interesting and relevant explanations in line 
with the literature on the economics of ICT and 
they deserve to be further analysed with additional 
empirical evidence. The labels we attached to 
the cluster intuitively convey the underlying 
hypotheses, that we could not tested for lack of 
variables on which the survey does not report 
information, such as for instance: a) individual 
respondent characteristics (age, experience, 
expertise, etc); b) information about processes 
and other input accompanying the deployment 
of eHealth in hospitals (human resources policy; 
organisation structure; organisational change).
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ls5 Discussion and recommendations
5.1 Methodological considerations: 
composite index and benchmarking
We have amply demonstrated that it cannot be 
decided a priori whether or not a Composite Index 
approach is appropriate for international policy 
benchmarking. Instead, it depends on the nature of 
the topic and of the data available and especially 
on the robustness and transparency of conceptual-
theoretical and methodological choices. 
The sheer amount and richness of the data from 
the eHealth Benchmarking Phase III survey would 
have been unmanageable from the perspective of 
making sense of it for policy purposes without the 
construction of a composite index.
When we set out to construct our CI, we 
made transparently clear those choices that 
depended on our conceptual and theoretical 
reasoning and the results that emerged simply 
from the multivariate statistical analysis of the 
data. No issue was left implicit and no arbitrary 
choices were made.  Critics may legitimately 
challenge our decision to weight the four 
dimensions equally, but we justified it with 
sensible reasoning and the weighting of the 
lower-level base variables. In the methodological 
and technical process, we followed standard 
practices from well-established handbooks and 
practical applications in the construction of CI. 
As a result of this, our Hospitals eHealth 
Deployment CI provides synthetic and interesting 
insights for policy makers that make sense and 
are robust, not only from an internal technical 
perspective but also with respect to the external 
exploratory checks we presented in § 4.2, of 
which two will suffice to recall that our CI was 
strongly corroborated. We showed that greater 
use of eHealth applications by medical staff is 
associated with a higher ranking in the Composite 
Index. We do not claim to have identified a 
causal relation whereby usage determines higher 
eHealth deployment in hospitals (or vice versa): 
more granular analysis controlling for other 
variables would be needed to make such a causal 
inference. On the other hand, if the association 
was negative, the soundness of our CI would have 
been challenged, but this is not the case. We also 
identified a clear trend linking higher levels of 
eHealth deployment in hospitals to more intensity 
(per capita) in spending on ICT in healthcare. 
Again, we are not making any causal inference 
from this trend, but we can certainly make better 
sense of the low ranking in the CI for countries such 
as Italy, France and Germany, in view of the fact 
that their intensity in ICT spending on healthcare 
is fairly low in relative terms compared to top 
Scandinavian countries and the UK. This does not 
necessarily mean that spending more on ICT and 
having higher levels of deployment of eHealth is 
better and produces more desirable outcomes. 
This issue should also be further analysed using the 
CI in combination with other data (more granular 
than the country aggregate indicators we used in 
§ 4.2, see more on this in 5.3). It means, however, 
that for the purposes for which it was constructed, 
our CI is fairly robust and sound.
As regards the latter, we are fairly confident 
about the capacity of our CI to meet the criteria 
of comparability and of accounting for country 
peculiarities. No doubts that other researchers 
can in the near future take our results and 
attempt a more in depth and possibly qualitative 
interpretation of the CI in view of country specific 
structural feature and/or short term policy efforts 
and dynamics. Nonetheless, we can safely affirm 
that the CI does not show any major bias with 
respect to comparability and country peculiarities. 
Moreover, the CI index and the summary indexes 
of the four dimensions should be read more for 
the information they provide about gaps than for 
the country ranking in itself (see more on this in 
the next paragraph on key policy messages).
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In conclusion, the synthetic information 
that can be extracted from the CI and from the 
dimensions summary indexes represents a unique 
contribution to the field of eHealth, which is 
more complete and exhaustive than any other 
analysis that has been published in Europe or 
beyond (including those published by the OECD 
and WHO) and places the European Commission 
at the leading edge in this field. In the light of this 
and also of other potential advancements in our 
understanding of eHealth that could be gained by 
linking the CI with other data, it would certainly 
be worth repeating the survey in the near future in 
order to develop the CI to benchmark progresses 
from this 2010 baseline. The approach we have 
adopted here, opportunely discussed and adapted 
could also be proposed as a model framework for 
both surveys and administrative data gathering on 
eHealth deployment and other relevant data.
5.2 Key policy messages
Despite very relevant comparability problems, 
we can risk concluding that the results of the 
eHealth Benchmarking Phase III survey show that 
progress has been made in Europe with respect 
to the levels of eHealth deployment registered 
in previous, less systematic and extensive data 
gathering activities such as Business Watch and 
Hine. For instance, the penetration of Electronic 
Patient Records (EPRs) has increased from the 
34% reported for 2006 by Business Watch to the 
current 81% [20].28 This 81% penetration of EPRs 
puts Europe way ahead of Japan and US, where 
only between 10% and 15% of hospitals have 
introduced them.
However, there are also several indications 
of areas in need of policy action, of which we 
emphasise the following four:
1. The CI shows large scope for 
improvement. The average EU27 CI 
28 See graph on page 208 of the Deloitte/Ipsos report. 
stands at 0.347, whereas that of top 
scoring Sweden is just slightly above 
0.5. This means that there is still room 
for general improvement.
2. Wide variation across countries. In 
particular, the lowest deployment 
measured by our CI is concentrated 
mostly among the new Member States 
and candidate countries. Of the bottom 
13 countries, 12 are from this group – 
Greece is the exception. The only new 
Member State that scores above the 
EU27 average is Estonia, confirming its 
excellence in the domain of ICT. This 
calls for awareness-raising policies and 
possibly financial support targeting this 
group of countries.
3. The summary indexes of the four 
dimensions identify areas to be 
prioritised. Whereas infrastructure 
deployment is quite high in most 
countries, electronic exchange of 
information lags behind fairly generally 
(across countries). It is important to 
close this gap, since these exchanges 
constitute one of the pillars of the 
vision and promises of ICT-supported 
integrated personal health services. 
These services are the key to producing 
better health outcomes while pursuing 
system sustainability and they must 
be developed around a seamless view 
of the user, for which exchange of 
information and timely clinical decisions 
are crucial. Yet, our analysis shows that 
electronic exchanges are still limited 
among the potential interacting players. 
Furthermore, cross-border exchanges 
are extremely limited, a gap that from 
the perspective of EU policy should be 
quickly addressed.
4. Predominant intramural orientation. 
From both simple descriptive statistics 
and from our multivariate statistical 
analysis, it emerges clearly that the 
deployment of eHealth in hospitals 
has been predominantly focussed on 
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intramural needs and applications. 
For instance, levels of deployment for 
Personal Health Records and home-
based Telemonitoring are very low. 
We need to stress that if the objectives 
and targets of the upcoming European 
Innovation Partnership on Active and 
Healthy Ageing are to be realised, 
much more progress will be needed 
in terms of both electronic exchange 
of information and user-oriented 
applications and services, such as PHR 
and Telemonitoring.
5.3 Linking hospitals’ eHealth 
deployment to other data
As argued in the OECD-JRC handbook of 
composite indicators on page 29: “Composite 
indicators often measure concepts that are linked 
to well-known and measurable phenomena, e.g. 
productivity growth, entry of new firms. These 
links can be used to test the explanatory power of 
a composite. Simple cross-plots are often the best 
way to illustrate such links”[60].  This is exactly 
what we have done in § 4.2. The same handbook 
warns not to infer causal relations from such cross-
plots, which we did not do. Instead, we verified that 
our CI was in line with common sense reasoning: 
if hospitals deploy eHealth applications in a more 
sustained fashion, they would spend more on ICT 
and this would be reflected at aggregate country 
level in ICT per capita spending on the healthcare 
system as a whole. This is exactly what we found, 
thus corroborating the robustness of our CI. Figure 
12 shows exactly how most countries are close to 
the trend line between the CI and ICT expenditure 
and there are only few outliers. We also used 
cross-plots with other data, and found trends that, 
in each case, supported the soundness of our CI.
Linking our CI to other data also alerted 
us to potential further research questions that 
could be addressed, should additional data 
become available by adding new modules to a 
future survey and/or integrating the survey with 
administrative data. Several questions arose, that 
would both advance our scientific understanding 
of the eHealth domain and contribute to policy 
making by identifying the impact of eHealth 
and/or the underlying factors and processes that 
explain success and should be the object of 
policy and innovation transfer efforts. We give 
just two examples below. 
Let us assume that, in addition to the data we 
have analysed, for the same sample of hospitals 
(so not at aggregate country level) we add only 
for a cross section also the following data: 
a) hospitals’ expenditure on ICT; 
b) hospitals’ output (i.e. number of 
consultations and/or number of 
treatments); 
c) measures of health status among the 
population served by these hospitals. 
With this data, we could apply a number 
of sophisticated techniques (such as Data 
Envelopment Analysis) and, controlling for 
different variables in different specifications, come 
closer to identifying causal relations. For instance, 
we could construct an outcome efficiency 
frontier using the CI of eHealth deployment while 
controlling for ICT expenditure and output, or we 
could construct the frontier crossing the CI and 
output while controlling for outcomes and other 
non-ICT input. Should data such as these become 
available in the future, then we would be able to 
infer causal relations and estimate the impact of 
eHealth deployment in hospitals, if any. 
In § 4.3, we analysed the answers of the 
MD when asked for their opinions on the extent 
to which EPRs and Telemonitoring contributed 
to achieving desirable outcomes. The simple 
analysis of descriptive statistics showed that 
while MD on average perceive some operational 
impacts which we labelled ‘throughput impact’ 
(i.e. increase in average number of patients the 
hospital can admit during one day), they do not 
see more strategic clinical and patient outcomes 
which we labelled ‘quality impact’ (i.e. quality 
of diagnosis and treatment). The multivariate 
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statistical analysis, however, identified four 
significant and meaningful clusters requiring an 
explanation. We called them: ‘laggards’ (MD who 
perceive no impact at all), ‘transformers’ (MD who 
perceive both throughput and quality impacts), 
‘rationalisers’ (MD who perceive only throughput 
impact), and ‘experimenters’ (MD who perceive 
only quality impact). These labels intuitively 
convey an underlying theoretical hypothesis 
derived from the microeconomics of ICT (i.e. 
‘transformers’ worked in hospitals where eHealth 
deployment was integrated with organisational 
restructuring and change management) that, 
however, the data from the survey did not allow 
us to empirically test. We could have tested this 
hypothesis and explained the difference between 
the clusters had the survey also contained the 
following: 
a) interviews with MD in all the hospitals 
in the sample; 
b) basic information about MDs’ personal 
characteristics (to control for the 
possibility that their perceptions are 
shaped by these characteristics rather 
than by the objective situation in the 
hospitals); 
c) information about re-organisation and 
change management in the hospitals 
(yes/no, when, for how long); 
d) the history of eHealth deployment in the 
hospital (to control for the possibility 
that in some hospitals, MD have not 
perceived any impact due to the lag 
time between eHealth implementation 
and the  its effects).
5.4 Final recommendations  
After the detailed presentation of results 
in the previous section and the discussion in 
the previous three paragraphs, the final policy 
recommendations should now be evident. We 
therefore limit ourselves to a brief summary of 
possible actions under two main headings: 
eHealth benchmarking and evaluation agenda
1. Replicate the survey on hospitals.  The 
survey should be replicated in 2011 or, 
at the latest, in 2012 to test the reliability 
if the CI and to benchmark progress. 
2. Link eHealth deployment to other data. 
Future surveys should include new 
modules to retrieve at least some of the 
additional data mentioned in § 5.3 in 
order to tackle wider research questions 
and contribute to impact evaluation 
objectives.
3. Work on Survey Model Framework. 
The above mentioned Units C4 and H1 
together with JRC-IPTS (and possibly 
DG SANCO) should engage the OECD 
and WHO in a joint project to develop 
such a framework for future use in both 
survey and administrative data gathering 
to ensure increased cross-sectional and 
longitudinal comparability in the future. 
eHealth policy agenda 
1. Awareness raising and financial support 
to low scoring countries. A targeted 
awareness raising campaign and new 
financial support instruments for the new 
Member States and candidate countries 
that are positioned at the bottom of our 
CI could be considered.
2. Measures to push Member States to 
close key gaps. Within the context of 
the new EIP on Active and Healthy 
Ageing, all Member States should be 
made aware of the fact that investment 
in eHealth within hospitals should 
give priority to increasing electronic 
exchanges of information and user-
oriented applications and services such 
as PHR and Telemonitoring.
3. Cross-border and digital single market. 
The information showing very limited 
deployment of eHealth in support of 
cross-border exchange should be used 
to justify placing this topic on the policy 
agenda within a digital single market 
perspective.
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Table 53: eHealth deployment Infrastructure. Mean and correlation matrix
Mean 1 2 3
Computer system connected .82
Broadband above 50 MBps .44 .150*
Hospital support wireless communications .54 .143* .133*
Hospital video conference facilities .41 .205* .266* .274*
* p<0.01.
Table 54: eHealth deployment application and integration. Mean and correlation matrix
Mean 1 2 3 4 5 6 7 8 9 10 11 12
Electronic Patient 
Record (EPR)
.81
Personal Health 
Record (PHR)
.05 .107*
Picture archiving 
and communication 
systems (PACS)
.61 .177* .053***
An integrated 
system for billing 
management
.77 .153* .037* .097*
An integrated system 
to send or receive 
electronic referral 
letters
.33 .222* .200* .248* .073**
An integrated system 
to send electronic 
discharge letters
.42 .228* .160* .223* .074** .513*
An integrated system 
for tele-radiology
.40 .173* .121* .443* .095* .204* .277*
A computerized 
system for 
ePrescribing
.30 .222* .168** .056** .160* .249* .256* .078**
An adverse health 
events report system
.42 .199* .078** .191* .159* .225* .179* .171* .294*
An electronic Clinical 
Tests
.70 .327* .091** .322* .154* .264* .266* .287* .192* .245*
An electronic service 
order placing? (e.g. 
test/diagnostic 
results)?
.56 .282* .077* .316* .173* .318* .296* .249* .157* .244* .410*
An electronic 
appointment booking 
system?
.70 .229* .091* .325* .275* .249* .251* .217* .158* .230* .304* .369*
Tele-homecare/tele-
monitoring services 
to outpatients (at 
home)?
.09 .079*** .136* .130* .074** .198* .145* .132* .141* .131* .094* .189* .160*
*p<.01 **p<.05 *** p<.1.
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Mean 1 2 3 4 5 6
Medical errors have been reduced 1.93
The quality of diagnosis decisions has improved 1.98 .426*
The quality of treatment decisions has improved 2.04 .480* .652*
The working processes of medical staff are more efficient 1.81 .276* .469* .357*
Waiting lists have been reduced 2.61 .170** .227* .231** .181**
Average number of patients your hospital can admit 
during one day has been increased
2.70 .337* .201** .316* .284* .483*
The amount of waste linked to unnecessary repetition of 
examinations has diminished
2.10 .244** .421* .290* .274* .265* .436*
* p<0.01 ** p<0.05 ***p<0.1.
Table 57: Possible impacts that the use of telemonitoring. Mean and correlation matrix
Mean 1 2 3 4 5 6 7
Improvement in the quality of life 
of patients
1.82
Reduction in the numbers and 
length of hospital stays
1.93 .548*
Reduction in medical errors 2.56 .310* .346*
Improvement in the quality of 
diagnosis decisions
2.32 .428* .420* .573*
Improvement in the quality of 
treatment decisions
2.18 .492* .486* .524* .795*
More efficient working processes 
among medical staff
1.94 .416* .542* .352* .405* .451*
Shorter waiting lists 2.15 .408* .486* .247* .314* .347* .481*
Increased average number of 
patients receiving help during 
one day
2.18 .487* .455* .279* .323* .322* .427* .604*
* p<0.01.
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